at http://kylejnorton.blogspot.ca/
Kyle J. Norton
The references page 1500 - 2333
(1500) Dietary magnesium intake and risk of cancer: a
meta-analysis of epidemiologic studies by Ko HJ1, Youn CH, Kim HM, Cho YJ, Lee
GH, Lee WK.(PubMed)
(1501) Magnesium and cancer: a dangerous liason by Castiglioni S1,
Maier JA.(PubMed)
(1502) Zinc, copper, and magnesium and risks for all-cause,
cancer, and cardiovascular mortality by Leone N1, Courbon D, Ducimetiere P,
Zureik M.(PubMed)
(1503) Porte Jr. D, Sherwin RS, Baron A (editors). Ellengerg &
Rifkin's Diabetes Mellitus, 6th Edition. McGraw-Hill , New York
(1504) Chromium Dietary Supplement Fact Sheet(NIH)
(1505) Dietary Reference Intakes Vitamin A, Vitamin K, Arsenic,
Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon,
Vanadium, and Zinc PAULA TRUMBO, PhD, ALLISON A YATES, PhD, RD, SANDRA SCHLICKER,
PhD, MARY POOS, PhD(Journal
of academic of nutrition and dietetics)
(1506) Chromium Deficiency During Total Parenteral Nutrition by
Herbert Freund, MD; Susan Atamian, RN; Josef E. Fischer, MD(Jama)
(1507) Chromium deficiency, glucose intolerance, and neuropathy
reversed by chromium supplementation, in a patient receiving long-term total
parenteral nutrition by Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR,
Bruce-Robertson A.(PubMed)
(1508) Chromium deficiency during total parenteral nutrition by
Freund H, Atamian S, Fischer JE.(PubMed)
(1509) Chromium level in prediction of diabetes in pre-diabetic
patients by Rafiei R1, Habyby Z1, Fouladi L1, Najafi S2, Asgary S3, Torabi Z4.(PubMed)
(1510) Chromium deficiency might contribute to insulin resistance,
type 2 diabetes mellitus, dyslipidaemia, and atherosclerosis by Mahdi GS.(PubMed)
(1511) Chromium in metabolic and cardiovascular disease by Hummel
M1, Standl E, Schnell O.(PubMed)
(1512) Effect of chromium nicotinic acid supplementation on
selected cardiovascular disease risk factors by Thomas VL1, Gropper SS.(PubMed)
(1513) Age-related decreases in chromium levels in 51,665 hair,
sweat, and serum samples from 40,872 patients--implications for the prevention
of cardiovascular disease and type II diabetes mellitus by Davies S1, McLaren
Howard J, Hunnisett A, Howard M.(PubMed)
(1514) [The significance of chromium for metabolic cardiovascular
syndrome]. [Article in Norwegian] by Naess K.(PubMed)
(1515) [The role of chromium in metabolic cardiovascular
syndrome]. [Article in Norwegian] by Naess K.(PubMed)
(1516) Effects of chromium and guar on sugar-induced hypertension
in rats by Preuss HG1, Gondal JA, Bustos E, Bushehri N, Lieberman S, Bryden NA,
Polansky MM, Anderson RA.(PubMed)
(1517) Comparative effects of chromium, vanadium and gymnema
sylvestre on sugar-induced blood pressure elevations in SHR by Preuss HG1,
Jarrell ST, Scheckenbach R, Lieberman S, Anderson RA.(PubMed)
(1518) Nutrigenomic basis of beneficial effects of chromium(III)
on obesity and diabetes by Lau FC1, Bagchi M, Sen CK, Bagchi D.(PubMed)
(1519) Chromium (D-phenylalanine)3 improves obesity-induced
cardiac contractile defect in ob/ob mice by Dong F1, Yang X, Sreejayan N, Ren J.(PubMed)
(1520) Effect of chromium supplementation on glycated hemoglobin
and fasting plasma glucose in patients with diabetes mellitus by Yin RV1, Phung
OJ2.(PubMed)
(1521) Chromium supplementation in impaired glucose tolerance of
elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels
by Uusitupa MI1, Mykkänen L, Siitonen O,
Laakso M, Sarlund H, Kolehmainen P, Räsänen T, Kumpulainen J, Pyörälä K.(PubMed)
(1522) Effect of chromium niacinate and chromium picolinate
supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated
hemoglobin,triglycerides, and cholesterol levels in blood of
streptozotocin-treated diabetic rats by Jain SK1, Rains JL, Croad JL.(PubMed)
(1523) The biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ decreases plasma
cholesterol and triglycerides in rats: towards chromium-containing therapeutics
by Sun Y1, Mallya K, Ramirez J, Vincent JB.(PubMed)
(1524) Lipoic acid (LA)(Wikipedia)
(1525) Alpha-lipoic acid is an effective inhibitor of human
immuno-deficiencyvirus (HIV-1) replication by Baur A1, Harrer T, Peukert M,
Jahn G, Kalden JR, Fleckenstein B.(PubMed)
(1526) Alpha-lipoic acid effects on brain glial functions
accompanying double-stranded RNA antiviral and inflammatory signaling by
Scumpia PO1, Kelly-Scumpia K1, Stevens BR2.(PubMed)
(1527) α-Lipoic acid enhances endogenous
peroxisome-proliferator-activated receptor-γ to ameliorate experimental
autoimmune encephalomyelitis in mice by Wang KC1, Tsai CP, Lee CL, Chen SY, Lin
GJ, Yen MH, Sytwu HK, Chen SJ.(PubMed)
(1528) Effects of lipoic acid on immune function, the antioxidant
defense system, and inflammation-related genes expression of broiler chickens
fed aflatoxin contaminated diets by Li Y1, Ma QG2, Zhao LH3, Wei H4, Duan GX5,
Zhang JY6, Ji C7.(PubMed)
(1529) Alpha-lipoic acid supplementation prevents symptoms of
vitamin E deficiency by Podda M1, Tritschler HJ, Ulrich H, Packer L.(PubMed)
(1530) Oxidative stress participates in the breakdown of neuronal
phenotype in experimental diabetic neuropathy by Hounsom L1, Corder R, Patel J, Tomlinson DR.(PubMed)
(1531) Circulating irisin and glucose metabolism in
overweight/obese women: effects of α-lipoic acid and eicosapentaenoic acid by
Huerta AE1, Prieto-Hontoria PL, Fernández-Galilea M, Sáinz N, Cuervo M,
Martínez JA, Moreno-Aliaga MJ.(PubMed)
(1532) Alpha-lipoic acid attenuates insulin resistance and
improves glucosemetabolism in high fat diet-fed mice. by Yang Y1, Li W2, Liu
Y2, Li Y2, Gao L3, Zhao JJ4.(PubMed)
(1533) Activation of JNK in sensory neurons protects against
sensory neuron cell death in diabetes and on exposure to glucose/oxidative
stress in vitro by Price SA1, Hounsom L, Purves-Tyson TD, Fernyhough P,
Tomlinson DR.(PubMed)
(1534) Nitrosative injury and antioxidant therapy in the
management of diabetic neuropathy by Cowell RM1, Russell JW.(PubMed)
(1355) Alpha-lipoic acid treatment reverses
2-deoxy-D-ribose-induced oxidative damage and suppression of insulin expression
in pancreatic beta-cells by Koh G1, Yang EJ, Kim MK, Lee SA, Lee DH.(PubMed)
(1556) Alpha-lipoic acid attenuates adipocyte differentiation and
lipid accumulation in 3T3-L1 cells via AMPK-dependent autophagy by Hahm JR1,
Noh HS2, Ha JH3, Roh GS4, Kim DR5.(PubMed)
(1557) Dyslipidemia and oxidative stress in PCOS by Macut D1,
Bjekić-Macut J, Savić-Radojević A.(PubMed)
(1558) (R)-(+)-α-lipoic acid protected NG108-15 cells against H₂O₂-induced
cell death through PI3K-Akt/GSK-3β pathway and suppression of NF-κβ-cytokines
by Kamarudin MN1, Mohd Raflee NA1, Hussein SS1, Lo JY1, Supriady H1, Abdul
Kadir H1.(PubMed)
(1559) Oxidative modification of lipoic acid by HNE in Alzheimer
disease brain by Hardas SS1, Sultana R, Clark AM, Beckett TL, Szweda LI, Murphy
MP, Butterfield DA.(PubMed)
(1560) The clinical efficacy of cosmeceutical application of
liquid crystalline nanostructured dispersions of alpha lipoic acid as
anti-wrinkle by Sherif S1, Bendas ER2,
Badawy S1.(PubMed)
(1561) Hypo-collagenesis in photoaged skin predicts response to
anti-agingcosmeceuticals by Sachs DL1, Rittié L, Chubb HA, Orringer J, Fisher
G, Voorhees JJ.(PubMed)
(1562) The effect of lipoic acid and vitamin E therapies in
individuals with the metabolic syndrome by Manning PJ1, Sutherland WH, Williams
SM, Walker RJ, Berry EA, De Jong SA, Ryalls AR.(PubMed)
(1563) α-Lipoic acid regulates lipid metabolism through induction
of sirtuin 1 (SIRT1) and activation of AMP-activated protein kinase by Chen
WL1, Kang CH, Wang SG, Lee HM.(PubMed)
(1564) Prevention of hypertension, insulin resistance, and
oxidative stress by alpha-lipoic acid by El Midaoui A1, de Champlain J.(PubMed)
(1565) The effects of α-lipoic acid on aortic injury and
hypertension in the rat remnant kidney (5/6 nephrectomy) model by Ergür BU1,
Cilaker Mıcılı S, Yılmaz O, Akokay P.(PubMed)
(1566) Alpha-lipoic acid supplementation: a tool for obesity
therapy? by Carbonelli MG1, Di Renzo L, Bigioni M, Di Daniele N, De Lorenzo A,
Fusco MA.(PubMed)
(1567) Anti-obesity effects of alpha-lipoic acid mediated by
suppression of hypothalamic AMP-activated protein kinase by Kim MS1, Park JY,
Namkoong C, Jang PG, Ryu JW, Song HS, Yun JY, Namgoong IS, Ha J, Park IS, Lee
IK, Viollet B, Youn JH, Lee HK, Lee KU.(PubMed)
(1568) α-lipoic acid can improve endothelial dysfunction in
subjects with impaired fasting glucose by Xiang G1, Pu J, Yue L, Hou J, Sun H.(PubMed)
(1569) The antioxidant alpha-lipoic acid improves endothelial
dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose
tolerance by Xiang GD1, Sun HL, Zhao LS, Hou J, Yue L, Xu L.(PubMed)
(1570) Revisiting the ALA/N (alpha-lipoic acid/low-dose
naltrexone) protocol for people with metastatic and nonmetastatic pancreatic
cancer: a report of 3 new cases by Berkson BM1, Rubin DM, Berkson AJ.(PubMed)
(1571) Chemopreventive potential of alpha lipoic acid in the
treatment of colon and cervix cancer cell lines by Damnjanovic I, Kocic G,
Najman S, Stojanovic S, Stojanovic D, Veljkovic A, Conic I, Langerholc T, Pesic
S.(PubMed)
(1572) The importance of 1,2-dithiolane structure in α-lipoic acid
for the downregulation of cell surface β1-integrin expression of human bladder
cancer cells by Yamasaki M1, Soda S, Sakakibara Y, Suiko M, Nishiyama K.(PubMed)
(1573) [Effect of tonifying kidney on compliability of the aged].
[Article in Chinese] by Xu JH1, Cui L, Jia BH.(PubMed)
(1574) Understanding Kidney Yin and Kidney Yang(Shen-Nong shi)
(1575) Kidney Yang Deficiency: Use Warming Foods and Moxibustion
By Jody Smith(Empow
her)
(1576) Metabolic Signatures of Kidney Yang Deficiency Syndrome and
Protective Effects of Two Herbal Extracts in Rats Using GC/TOF MS by Zhao L1, Wu H, Qiu M, Sun W, Wei R, Zheng X, Yang
Y, Xin X, Zou H, Chen T, Liu J, Lu L, Su J, Ma C, Zhao A, Jia W.(PubMed)
(1577) Metabolic profiling reveals therapeutic biomarkers of processed
Aconitum carmichaeli Debx in treating hydrocortisone induced kidney-yang
deficiency syndrome rats by Tan Y1, Liu
X2, Lu C3, He X1, Li J4, Xiao C5, Jiang M1, Yang J1, Zhou K6, Zhang Z2, Zhang
W7, Lu A8.(PubMed)
(1578) [Multi-center randomized control study on the effects of
syndromedifferentiated traditional Chinese medicine therapy on CKD 1-2 with
chronic nephritis proteinuria].
[Article in Chinese] by Wu F, Zhang PQ, Wang XQ, Nie
LF, Fu XJ, Peng W, Wang Y, Li J, Bi YP, Mi XH, Ding XQ, He LQ.(PubMed)
(1579) [Effect of Chinese herbs on the circadian rhythm of body
temperature and heart rate in rabbits with hypothyroidism (yang
deficiency)].[Article in Chinese by Xu M1, Deng X, Zhang X, Liu S, Liu X.(PubMed)
(1580) Chinese acupuncture for chronic low back pain: an
international expert survey by Molsberger AF1, Zhou J, Arndt D, Teske W.(PubMed)
(1581) [Preliminary study on relationship of
disease-syndrome-symptom of ovulatory disorder infertility based on factor
analysis].[Article in Chinese] by Li M, Ma K, Shan J.(PubMed)
(1582) Traditional chinese medicine syndromes for essential
hypertension: a literature analysis of 13,272 patients by Wang J1, Xiong X1, Liu W1.(PubMed) (1583)
Polycystic Ovary Syndrome - a TCM Perspective by Donna Dupre, L.Ac.
(1586) Da Suan, Garlic(Complementary and Alternative
Healing University)
(1587) Garlic for the common cold by Lissiman E1, Bhasale AL,
Cohen M.(PubMed)
(1588) Preventing the common cold with a garlic supplement: a
double-blind, placebo-controlled survey by Josling P1.(PubMed)
(1589) Supplementation with aged garlic extract improves both NK
and γδ-T cell function and reduces the severity of cold and flu symptoms: a
randomized, double-blind, placebo-controlled nutrition intervention by Nantz
MP1, Rowe CA, Muller CE, Creasy RA, Stanilka JM, Percival SS.(PubMed)
(1590)A strategic call to utilize Echinacea-garlic in flu-cold
seasons by Abdullah T.(PubMed)
(1591) Garlic for hypertension: A systematic review and meta-analysis
of randomized controlled trials by Xiong XJ1, Wang PQ2, Li SJ3, Li XK4, Zhang YQ5,
Wang J6.(PubMed)
(1592) Aged garlic extract lowers blood pressure in patients with
treated but uncontrolled hypertension: a randomised controlled trial by Ried
K1, Frank OR, Stocks NP.(PubMed)
(1593) Cholesterol-lowering effect of garlic extracts and organosulfur
compounds: human and animal studies by Yeh YY1, Liu L.(PubMed)
(1594) Inhibition of cholesterol biosynthesis by organosulfur
compounds derived from garlic by Liu L1, Yeh YY.(PubMed)
(1595) A comparison of the antimicrobial activity of garlic,
ginger, carrot, and turmeric pastes against Escherichia coli O157:H7 in
laboratory buffer and ground beef by Gupta S1, Ravishankar S.(PubMed)
(1596) Antimicrobial activity of garlic, tea tree oil, and
chlorhexidine against oral microorganisms by Groppo FC1, Ramacciato JC, Simões RP, Flório FM,
Sartoratto A.(PubMed)
(1597) Garlic consumption and cancer prevention: meta-analyses of
colorectal and stomach cancers by Fleischauer AT1, Poole C, Arab L.(PubMed)
(1598) Garlic and cancer: a critical review of the epidemiologic
literature by Fleischauer AT1, Arab L.(PubMed)
(1599) Consumption of garlic and risk of colorectal cancer: an
updated meta-analysis of prospective studies by Hu JY1, Hu YW1, Zhou JJ1, Zhang
MW1, Li D1, Zheng S1.(PubMed)
(1601) Garlic essential oil protects against obesity-triggered
nonalcoholic fatty liver disease through modulation of lipid metabolism and
oxidative stress by Lai YS1, Chen WC, Ho CT, Lu KH, Lin SH, Tseng HC, Lin SY,
Sheen LY.(PubMed)
(1602) Potential protective effects of Nigella sativa and Allium
sativum against fructose-induced metabolic syndrome in rats by Al-Rasheed N1,
Al-Rasheed N, Bassiouni Y, Faddah L, Mohamad AM.(PubMed)
(1603) Medicinal agents and metabolic syndrome by Rubio-Ruiz ME1,
El Hafidi M, Pérez-Torres I, Baños G, Guarner V.(PubMed)
(1604) Including garlic in the diet may help lower blood glucose,
cholesterol, and triglycerides by Thomson M1, Al-Qattan KK, Bordia T, Ali M.(PubMed)
(1605) Influence of garlic on serum cholesterol, serum
triglycerides, serum total lipids and serum glucose in human subjects by Bakhsh
R, Chughtai MI.(PubMed)
(1606) Attenuation of oxidative stress, inflammation and insulin
resistance by allium sativum in fructose-fed male rats by K S1, Senthilkumar
GP, Sankar P, Bobby Z.(PubMed)
(1607) Garlic improves insulin sensitivity and associated
metabolic syndromes in fructose fed rats by Padiya R1, Khatua TN, Bagul PK, Kuncha M, Banerjee
SK.(PubMed)
(1608) Alliin, a garlic (Allium sativum) compound, prevents
LPS-inducedinflammation in 3T3-L1 adipocytes by Quintero-Fabián S1, Ortuño-Sahagún
D2, Vázquez-Carrera M3, López-Roa RI4.(PubMed)
(1609) Diallyl trisulfide ameliorates arsenic-induced
hepatotoxicity by abrogation of oxidative stress, inflammation, and apoptosis
in rats by Sumedha NC1, Miltonprabu S2.(PubMed)
(1610) Aged garlic extract attenuates gentamicin induced renal
damage and oxidative stress in rats by Maldonado PD1, Barrera D, Medina-Campos
ON, Hernández-Pando R, Ibarra-Rubio ME, Pedraza-Chaverrí J.(PubMed)
(1611) Antioxidant S-allylcysteine prevents gentamicin-induced
oxidative stress and renal damage by Maldonado PD1, Barrera D, Rivero I, Mata
R, Medina-Campos ON, Hernández-Pando R, Pedraza-Chaverrí J.(PubMed)
(1612) Garlic and cardiovascular disease: a critical review by
Rahman K1, Lowe GM.(PubMed)
(1613) Role of garlic usage in cardiovascular disease prevention:
an evidence-based approach by Qidwai W1, Ashfaq T.(PubMed)
(1614 1615)
(1616) Chinese Herbs – Jiang (Rhizoma zingiberis officinalis) by Kyle J. Norton
(1617) Jiang(Complementary
and Alternative Healing University)
(1618) Influence of ginger and cinnamon intake on inflammation and
muscle soreness endued by exercise in Iranian female athletes by Mashhadi NS1,
Ghiasvand R, Askari G, Feizi A, Hariri M, Darvishi L, Barani A, Taghiyar M,
Shiranian A, Hajishafiee M.(PubMed)
(1619) Dietary influence on pain via the immune system by Totsch
SK1, Waite ME1, Sorge RE2.(PubMed)
(1620) Anti-inflammatory effects of zingiber officinale in type 2
diabetic patients by Mahluji S1, Ostadrahimi A, Mobasseri M, Ebrahimzade Attari
V, Payahoo L.(PubMed)
(1621) Anticoagulant activity of select dietary supplements by
Stanger MJ1, Thompson LA, Young AJ, Lieberman HR.(PubMed)
(1622) Antithrombotic effects of naturally derived products on
coagulation and platelet function by Mousa SA1.(PubMed)
(1623) The effectiveness of Swedish massage with aromatic ginger
oil in treating chronic low back pain in older adults: a randomized controlled
trial by Sritoomma N1, Moyle W2, Cooke M3, O'Dwyer S4.(PubMed)
(1624) Evidence of effectiveness of herbal antiinflammatory drugs
in the treatment of painful osteoarthritis and chronic low back pain by
Chrubasik JE1, Roufogalis BD, Chrubasik S.(PubMed)
(1625) In vitro and in vivo anti-allergic effects of 'benifuuki'
green tea containing O-methylated catechin and ginger extract enhancement by
Maeda-Yamamoto M1, Ema K, Shibuichi I.(PubMed)
(1626) Ginger prevents Th2-mediated immune responses in a mouse
model of airway inflammation by Ahui ML1,
Champy P, Ramadan A, Pham Van L, Araujo L, Brou André K, Diem S, Damotte D,
Kati-Coulibaly S, Offoumou MA, Dy M, Thieblemont N, Herbelin A.(PubMed)
( 1627) Ginger extract (Zingiber officinale) has anti-cancer and
anti-inflammatory effects on ethionine-induced hepatoma rats by Habib SH1,
Makpol S, Abdul Hamid NA, Das S, Ngah WZ, Yusof YA.(PubMed)
(1628) Chemopreventive efficacy of ginger (Zingiber officinale) in
ethionine induced rat hepatocarcinogenesis by Yusof YA1, Ahmad N, Das S, Sulaiman S, Murad NA.(PubMed)
(1629) 6-Gingerol inhibits hair shaft growth in cultured human
hair follicles and modulates hair growth in mice by Miao Y1, Sun Y, Wang W, Du
B, Xiao SE, Hu Y, Hu Z.(PubMed)
(1630) [Inhibition effect of 6-gingerol on hair growth].[Article
in Chinese] by Miao Y, Sun YB, Wang WJ, Zhang ZD, Jiang JD, Li ZH, Hu ZQ.(PubMed)
(1631) Complementary and alternative medicine use and cost in
functional bowel disorders: a six month prospective study in a large HMO by van
Tilburg MA1, Palsson OS, Levy RL, Feld AD, Turner MJ, Drossman DA, Whitehead
WE.(PubMed)
(1632) Targeting inflammation-induced obesity and metabolic
diseases by curcumin and other nutraceuticals by Aggarwal BB1.(PubMed)
(1633) Synthesis of a new [6]-gingerol analogue and its protective
effect with respect to the development of metabolic syndrome in mice fed a
high-fat diet by Okamoto M1, Irii H, Tahara Y, Ishii H, Hirao A, Udagawa H,
Hiramoto M, Yasuda K, Takanishi A, Shibata S, Shimizu I.(PubMed)
(1634) Modulatory effects of garlic, ginger, turmeric and their
mixture on hyperglycaemia, dyslipidaemia and oxidative stress in streptozotocin-nicotinamide
diabetic rats by Madkor HR1, Mansour SW, Ramadan G.(PubMed)
(1635) Comparative effects of dietary ginger (Zingiber officinale)
and garlic (Allium sativum) investigated in a type 2 diabetes model of rats by
Islam MS1, Choi H.(PubMed)
(1636) Protective effects of ethanolic extract of Zingiber
officinale rhizome on the development of metabolic syndrome in high-fat
diet-fed rats by Nammi S1, Sreemantula S, Roufogalis BD.(PubMed)
(1637) The anti-oxidant effects of ginger and cinnamon on
spermatogenesis dys-function of diabetes rats by Khaki A1, Khaki AA1,
Hajhosseini L2, Golzar FS1, Ainehchi N1(PubMed)
(1638) Phytochemical and nutritional composition of Walnut (M. D. idea)
(1639) Nut consumption has favorable effects on lipid profiles of
Korean women with metabolic syndrome by Lee YJ1, Nam GE2, Seo JA3, Yoon T1, Seo
I1, Lee JH1, Im D1, Bahn KN1, Jeong SA1, Kang TS1, Ahn JH3, Kim do H4, Kim
NH5.(PubMed)
(1640) Clustering of haemostatic variables and the effect of high
cashew and walnut diets on these variables in metabolic syndrome patients by
Pieters M1, Oosthuizen W, Jerling JC, Loots DT, Mukuddem-Petersen J, Hanekom
SM.(PubMed)
(1641) Effects of walnuts on endothelial function in overweight
adults with visceral obesity: a randomized, controlled, crossover trial by Katz
DL1, Davidhi A, Ma Y, Kavak Y, Bifulco L, Njike VY.(PubMed)
(1642) Protective effects of ethanolic extract of Zingiber
officinale rhizome on the development of metabolic syndrome in high-fat
diet-fed rats by Nammi S1, Sreemantula
S, Roufogalis BD.(PubMed)
(1643) Walnut consumption is associated with lower risk of type 2
diabetes in women by Pan A1, Sun Q, Manson JE, Willett WC, Hu FB.(PubMed)
(1644) Effect of the walnut polyphenol fraction on oxidative
stress in type 2 diabetes mice by Fukuda T1, Ito H, Yoshida T.(PubMed)
(1645) Effects of walnut consumption on blood lipids and other
cardiovascular risk factors: a meta-analysis and systematic review by Banel
DK1, Hu FB.(PubMed)
(1646) Effects of walnut consumption as part of a low-fat,
low-cholesterol diet on serum cardiovascular risk factors by Morgan JM1, Horton
K, Reese D, Carey C, Walker K, Capuzzi DM.(PubMed)
(1647) Enzymatically interesterified fats based on mutton tallow
and walnut oil suitable for cosmetic emulsions by Kowalska M1, Mendrycka M,
Zbikowska A, Stawarz S.(PubMed)
(1648) Juglans regia and J. nigra, two trees important in
traditional medicine: A comparison of leaf essential oil compositions and
biological activities by Paudel P1, Satyal P1, Dosoky NS1, Maharjan S2, Setzer
WN1.(PubMed)
(1649) Walnut diet reduces accumulation of polyubiquitinated
proteins and inflammation in the brain of aged rats by Poulose SM1, Bielinski
DF, Shukitt-Hale B.(PubMed)
(1650) Juglans mandshurica leaf extract protects skin fibroblasts
from damage by regulating the oxidative defense system by Park G1, Jang DS, Oh
MS.(PubMed)
(1651) Inhibitory effects of Juglans mandshurica leaf on allergic
dermatitis-like skin lesions-induced by 2,4-dinitrochlorobenzene in mice by
Park G1, Oh MS2.(PubMed)
(1652) In vitro antioxidant activity of Juglans regia L. bark
extract and its protective effect on cyclophosphamide-induced urotoxicity in
mice by Bhatia K1, Rahman S, Ali M, Raisuddin S.(PubMed)
(1653) Royal bee jelly(Complementary and
Alternative Healing University)
(1654) Long-term administration of Greek Royal Jelly improves
spatial memory and influences the concentration of brain neurotransmitters in
naturally aged Wistar male rats by Pyrzanowska J1, Piechal A1, Blecharz-Klin K1,
Joniec-Maciejak I1, Graikou K2, Chinou I2, Widy-Tyszkiewicz E3.(PubMed)
(1655) Royal jelly prevents the progression of sarcopenia in aged
mice in vivo and in vitro by Niu K1, Guo H, Guo Y, Ebihara S, Asada M, Ohrui T,
Furukawa K, Ichinose M, Yanai K, Kudo Y, Arai H, Okazaki T, Nagatomi R.(PubMed)
(1656) In-depth phosphoproteomic analysis of royal jelly derived
from western and eastern honeybee species by Han B1, Fang Y, Feng M, Lu X, Huo X, Meng L, Wu
B, Li J.(PubMed)
(1657) Royal jelly modulates oxidative stress and apoptosis in
liver and kidneys of rats treated with cisplatin by Karadeniz A1, Simsek N,
Karakus E, Yildirim S, Kara A, Can I, Kisa F, Emre H, Turkeli M.(PubMed)
(1658) Serum and liver tissue bio-element levels, and antioxidant
enzyme activities in carbon tetrachloride-induced hepatotoxicity: protective
effects of royal jelly by Cemek M1, Yılmaz F, Büyükokuroğlu ME, Büyükben A,
Aymelek F, Ayaz A.(PubMed)
(1659) The effects of royal jelly on liver damage induced by
paracetamol in mice by Kanbur M1, Eraslan G, Beyaz L, Silici S, Liman BC,
Altinordulu S, Atasever A.(PubMed)
(1660) The efficacy of topical royal jelly on healing of diabetic
foot ulcers: a double-blind placebo-controlled clinical trial by Siavash M1,
Shokri S, Haghighi S, Shahtalebi MA, Farajzadehgan Z.(PubMed)
(1661) [Influence of honey, royal jelly and propolis on
accelerating acetate healing of experimental gastric ulcers in rats].[Article
in Russian] by Belostotskiĭ NI, Kas'ianenko VI, Dubtsova EA, Lazebnik LB.(PubMed)
(1662) Complementary and alternative medicine in children with
asthma by Orhan F1, Sekerel BE, Kocabas CN, Sackesen C, Adalioglu G, Tuncer A.(PubMed)
(1663) Asthma following royal jelly by Harwood M, Harding S,
Beasley R, Frankish PD.(PubMed)
(1664) Effects of royal jelly supplementation on body weight and
dietary intake in type 2 diabetic females by Pourmoradian S1, Mahdavi R2,
Mobasseri M3, Faramarzi E1, Mobasseri M4.(PubMed)
(1665) Effects of royal jelly supplementation on glycemic control
and oxidative stress factors in type 2 diabetic female: a randomized clinical
trial by Pourmoradian S1, Mahdavi R, Mobasseri M, Faramarzi E, Mobasseri M.(PubMed)
(1666) Antihypertensive activities of royal jelly protein
hydrolysate and its fractions in spontaneously hypertensive rats by Takaki-Doi
S1, Hashimoto K, Yamamura M, Kamei C.(PubMed)
(1667) Antihypertensive effect of peptides from royal jelly in
spontaneously hypertensive rats by Tokunaga KH1, Yoshida C, Suzuki KM, Maruyama H,
Futamura Y, Araki Y, Mishima S.(PubMed)
(1668) Effect of Memo®, a natural formula combination, on
Mini-Mental State Examination scores in patients with mild cognitive impairment
by Yakoot M1, Salem A, Helmy S.(PubMed)
(1669) Raw drone milk of honeybees elicits uterotrophic effect in
rats: evidence for estrogenic activity by Seres AB1, Ducza E, Báthori M, Hunyadi A, Béni Z,
Dékány M, Gáspár R.(PubMed)
(1670) Royal jelly has estrogenic effects in vitro and in vivo by
Mishima S1, Suzuki KM, Isohama Y, Kuratsu N, Araki Y, Inoue M, Miyata T.(PubMed)
(1671) Effect of Royal Jelly on premenstrual syndrome among
Iranian medical sciences students: a randomized, triple-blind,
placebo-controlled study by Taavoni S1, Barkhordari F2, Goushegir A3, Haghani
H4.(PubMed)
(1672) Towards a molecular definition of worker sterility:
differential gene expression and reproductive plasticity in honey bees by
Thompson GJ1, Kucharski R, Maleszka R, Oldroyd BP.(PubMed)
(1673) Effect of royal jelly ingestion for six months on healthy
volunteers by Hiroyuki Morita,
1 Takahide Ikeda,1 Kazuo Kajita,1 Kei
Fujioka,1 Ichiro Mori,1 Hideyuki Okada,1 Yoshihiro Uno,1 and Tatsuo Ishizuka.(PubMed)
1 Takahide Ikeda,1 Kazuo Kajita,1 Kei
Fujioka,1 Ichiro Mori,1 Hideyuki Okada,1 Yoshihiro Uno,1 and Tatsuo Ishizuka.(PubMed)
(1674) Immune defense and antibacterial activity In-depth phosphoproteomic
analysis of royal jelly derived from western and eastern honeybee species by
Han B1, Fang Y, Feng M, Lu X, Huo X, Meng L, Wu B, Li J.(PubMed)
(1675) Royal jelly increases high density lipoprotein levels but
in older patients only by Münstedt K, Henschel M, Hauenschild A, von Georgi R.(PubMed)
(1676) Effects of Royal Jelly Supplementation on Body Weight and
Dietary Intake in Type 2 Diabetic Females by Samira Pourmoradian, 1 Reza
Mahdavi, 2 ,* Majid Mobasseri, 3 Elnaz Faramarzi, 1 and Mehrnoosh Mobasseri(PubMed)
(1677) Royal jelly ameliorates insulin resistance in
fructose-drinking rats by Zamami Y1, Takatori S, Goda M, Koyama T, Iwatani Y,
Jin X, Takai-Doi S, Kawasaki H.(PubMed)
(1678) Effects of royal jelly supplementation on glycemic control
and oxidative stress factors in type 2 diabetic female: a randomized clinical
trial by Pourmoradian S1, Mahdavi R, Mobasseri M, Faramarzi E, Mobasseri M.(PubMed)
(1679) [Effect of long-term treatment with royal jelly on insulin
resistance in Otsuka Long-Evans Tokushima Fatty (OLETF) rats].[Article in
Japanese] by Nomura M1, Maruo N, Zamami Y, Takatori S, Doi S, Kawasaki H.(PubMed)
(1680) Study on the effect of royal jelly on reproductive
parameters in streptozotocin-induced diabetic rats by Ghanbari E1, Nejati V1,
Najafi G2, Khazaei M3, Babaei M2.(PubMed)
(1681) Protective effect of royal jelly on fertility and
biochemical parameters in bleomycin-induced male rats
by Amirshahi T1, Najafi G2, Nejati V1.(PubMed)
(1682) Antifatigue effect of fresh royal jelly in mice by Kamakura
M1, Mitani N, Fukuda T, Fukushima M.(PubMed)
(1683) Antidepressant-like activity of 10-hydroxy-trans-2-decenoic
Acid, a unique unsaturated Fatty Acid of royal jelly, in stress-inducible
depression-like mouse model by Ito S1, Nitta Y, Fukumitsu H, Soumiya H, Ikeno
K, Nakamura T, Furukawa S.(PubMed)
(1684) GE132+Natural: Novel promising dietetic supplement with
antiproliferative influence on prostate, colon, and breast cancer cells by
Okic-Djordjevic I1, Trivanovic D, Krstic
J, Jaukovic A, Mojsilovic S, Santibanez JF, Terzic M, Vesovic D, Bugarski D.(PubMed)
(1685) Effect of royal jelly on bisphenol A-induced proliferation
of human breast cancer cells by Nakaya M1, Onda H, Sasaki K, Yukiyoshi A,
Tachibana H, Yamada K.(PubMed)
(1686) Mu dan pi(Complementary
and Alternative Healing University)
(1687) Effect of traditional Chinese medicinal herbs on Candida spp.
from patients with HIV/AIDS by Liu X1,
Han Y, Peng K, Liu Y, Li J, Liu H.(PubMed)
(1688) Potent anti-microbial activity of traditional Chinese medicine
herbs against Candida species by Seneviratne CJ1, Wong RW, Samaranayake LP.(PubMed)
(1689) Inhibitory effects of Moutan cortex on immediate allergic
reactions by Jiang S1, Nakano Y, Yatsuzuka R, Ono R, Kamei C.(PubMed)
(1690) [Pharmacological of cortex moutan and core][Article in
Chinese] by Li Y1, Zhang W, Huang L, Shi J.(PubMed)
(1691) Screening of bioactive compounds from moutan cortex and
their anti-inflammatory activities in rat synoviocytes by Wu M1, Gu Z.(PubMed)
(1692) Anti-inflammatory and anti-allergic activities of Pentaherb
formula, Moutan Cortex (Danpi) and gallic acid by Liu KY1, Hu S, Chan BC, Wat
EC, Lau CB, Hon KL, Fung KP, Leung PC, Hui PC, Lam CW, Wong CK.(PubMed)
(1693) Screening of a polar extract of Paeonia rockii: composition
and antioxidant and antifungal activities by Picerno P1, Mencherini T, Sansone
F, Del Gaudio P, Granata I, Porta A, Aquino RP.(PubMed)
(1694) Effects of paeonol on anti-neuroinflammatory responses in
microglial cells by Lin C1, Lin HY2, Chen JH3, Tseng WP4, Ko PY5, Liu YS6, Yeh
WL7, Lu DY8,9.(PubMed)
(1695) [Pharmacological studies on the root bark of Paeonia
moutan. II. Anti-inflammatory effect, preventive effect on stress-induced
gastric erosion, inhibitory effect on gastric juice secretion and other effects
of paeonol].[Article in Japanese] by Harada M, Yamashita A, Aburada M.(PubMed)
(1696) Herbal medicine for the management of polycystic ovary
syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review
of the laboratory evidence for effects with corroborative clinical findings by
Arentz S, Abbott JA, Smith CA, Bensoussan A.(PubMed)
(1697) Anti-hypertensive effects of
shichimotsukokato in 5/6 nephrectomized Wistar rats mediated by the
DDAH-ADMA-NO pathway by Bai F1, Makino
T, Ono T, Mizukami H.(PubMed)
(1698) Effects of paeoniflorin on tumor necrosis factor-α-induced
insulin resistance and changes of adipokines in 3T3-L1 adipocytes by Kong P1,
Chi R, Zhang L, Wang N, Lu Y.(PubMed)
(1699) [Effects of total glucosides of paeony on enhancing insulin
sensitivity and antagonizing nonalcoholic fatty liver in rats].[Article in
Chinese] by Zheng LY1, Pan JQ, Lv JH.(PubMed)
(1700) Novel effect of paeonol on the formation of foam cells:
promotion of LXRα-ABCA1-dependent cholesterol efflux in macrophages by Zhao
JF1, Jim Leu SJ, Shyue SK, Su KH, Wei J, Lee TS.(PubMed)
(1701) Review of the effects of the traditional Chinese medicine
Rehmannia Six Formula on diabetes mellitus and its complications by Poon TY1, Ong KL, Cheung BM.(PubMed)
(1702) Natural products: a safest approach for obesity by Vasudeva
N1, Yadav N, Sharma SK.(PubMed)
(1703) Protection by tree-peony (Paeonia suffruticosa Andr) of
obesity in (SLN x C3H/He) F1 obese mice by Nagasawa H1, Iwabuchi T, Inatomi H.(PubMed)
(1704) Immunomodulatory and Antidiabetic Effects of a New Herbal
Preparation (HemoHIM) on Streptozotocin-Induced Diabetic Mice by Kim JJ1, Choi
J1, Lee MK2, Kang KY3, Paik MJ3, Jo SK4, Jung U4, Park HR4, Yee ST5.(PubMed)
(1705) Neuroprotective effect of paeoniflorin on cerebral ischemic
rat by activating adenosine A1 receptor in a manner different from its
classical agonists by Liu DZ1, Xie KQ, Ji XQ, Ye Y, Jiang CL, Zhu XZ.(PubMed)
(1706) Cardioprotective effect of total paeony glycosides against
isoprenaline-induced myocardial ischemia in rats by Long J1, Gao M, Kong Y,
Shen X, Du X, Son YO, Shi X, Liu J, Mo X.(PubMed)
(1707) Cardioprotective effect of gallic acid on cardiac
troponin-T, cardiac marker enzymes, lipid peroxidation products and
antioxidants in experimentally induced myocardial infarction in Wistar rats by
Priscilla DH1, Prince PS.(PubMed)
(1708) Effects of total glucosides from paeony (Paeonia lactiflora
Pall) roots on experimental atherosclerosis in rats by Li J1, Chen CX, Shen
YH.(PubMed)
(1709) Pachymic Acid Inhibits Growth and Induces Apoptosis of
Pancreatic Cancer In Vitro and In Vivo by Targeting ER Stress by Cheng S1,
Swanson K1, Eliaz I2, McClintick JN3, Sandusky GE4, Sliva D5.(PubMed)
(1710) Induction of apoptosis in prostate cancer cells by pachymic
acid from Poria cocos by Gapter L1, Wang Z, Glinski J, Ng KY.(PubMed)
(1711) Fu ling(Complementary and
Alternative Healing University)
(1712) Chemical constituents and pharmacological properties of
Poria cocos by Ríos JL1.(PubMed)
(1713) [Chemical constituents of surface layer of Poria cocos and
their pharmacological properties (I)].[Article in Chinese] by Feng YL1, Zhao
YY, Ding F, Xi ZH, Tian T, Zhou F, Du X, Chen DQ, Wei F, Cheng XL, Lin RC.(PubMed)
(1714) Effects of triterpenoids from Poria cocos Wolf on the
serotonin type 3A receptor-mediated ion current in Xenopus oocytes by Lee JH1,
Lee YJ, Shin JK, Nam JW, Nah SY, Kim SH, Jeong JH, Kim Y, Shin M, Hong M, Seo
EK, Bae H.(PubMed)
(1715) [Study on medication regularity of grand master of
traditional Chinese medicine YAN Zheng-hua's Ostreae Concha-containing
prescriptions based on data mining].[Article in Chinese] by Wu JR, Guo WX, Zhang
XM, Yang B, Zhang B.(PubMed)
(1716) Prescription of chinese herbal medicine and selection of
acupoints in pattern-based traditional chinese medicine treatment for insomnia:
a systematic review by Yeung WF1, Chung KF, Poon MM, Ho FY, Zhang SP, Zhang ZJ,
Ziea ET, Wong Taam V.(PubMed)
(1717) Smart Soup, a traditional Chinese medicine formula,
ameliorates amyloid pathology and related cognitive deficits by Hou Y1, Wang
Y2, Zhao J1, Li X1, Cui J1, Ding J2, Wang Y3, Zeng X1, Ling Y4, Shen X5, Chen
S2, Huang C4, Pei G6.(PubMed)
(1718) Ameliorative effects of yokukansan on learning and memory
deficits in olfactory bulbectomized mice by Yamada M1, Hayashida M, Zhao Q,
Shibahara N, Tanaka K, Miyata T, Matsumoto K.(PubMed)
(1719) Treatment with qibaomeiran, a kidney-invigorating Chinese
herbal formula, antagonizes estrogen decline in ovariectomized rats by Xu Y1,
Ma XP, Ding J, Liu ZL, Song ZQ, Liu HN, Lin N.(PubMed)
(1720) Antioxidant activity of anti-inflammatory plant extracts by
Schinella GR1, Tournier HA, Prieto JM, Mordujovich de Buschiazzo P, Ríos JL.(PubMed)
(1721) Oriental medicine Kyung-Ok-Ko prevents and alleviates
dehydroepiandrosterone-induced polycystic ovarian syndrome in rats by Jang M1,
Lee MJ1, Lee JM2, Bae CS3, Kim SH4, Ryu JH5, Cho IH6.(PubMed)
(1722) Metabolism[Effects of Chinese herb decoction sizunzituang
on metabolism and nutrition in burnt guinea pigs].[Article in Chinese] by Ruan
S1, Wang S, Li A.(PubMed)
(1723) Anti-Hyperglycemic Properties of Crude Extract and
Triterpenes from Poria cocos by Li TH1,
Hou CC, Chang CL, Yang WC.(PubMed)
(1724) Di Huang(Complementary and Alternative
Healing University)
(1725) Stachyose extract from Rehmannia glutinosa Libosch. to
lower plasma glucose in normal and diabetic rats by oral administration by
Zhang RX1, Jia ZP, Kong LY, Ma HP, Ren J, Li MX, Ge X.(PubMed)
(1726) Hypoglycemic effect of Rehmannia glutinosa oligosaccharide
in hyperglycemic and alloxan-induced diabetic rats and its mechanism by Zhang
R1, Zhou J, Jia Z, Zhang Y, Gu G.(PubMed)
(1727) Plasma glucose lowering mechanisms of catalpol, an active
principle from roots of Rehmannia glutinosa, in streptozotocin-induced diabetic
rats by Shieh JP1, Cheng KC, Chung HH, Kerh YF, Yeh CH, Cheng JT.(PubMed)
(1728) Evaluation of symptom, clinical chemistry and metabolomics
profiles during Rehmannia six formula (R6) treatment: an integrated and
personalized data analysis approach by van Wietmarschen HA1, van der Greef J,
Schroën Y, Wang M.(PubMed)
(1729) The protective effect of Liu-Wei-Di-Huang-Fang in
salt-sensitive hypertension rats byYang Q1, He Y, Wang W.(PubMed)
(1730) [Effect of Rehmannia glutinosa water extraction on insulin
resistance and gene expression of resistin in type 2 diabetes mellitus rats].
[Article in Chinese] by Lv XF1, Meng QY, Guo XM.(PubMed)
(1731) Catalpol Inhibited the Proliferation of T24 Human Bladder
Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated
Anti-apoptotic Signaling by Jin D1, Cao M, Mu X, Yang G, Xue W, Huang Y, Chen
H.(PubMed)
(1732) Hot water-extracted Lycium barbarum and Rehmannia glutinosa
inhibit proliferation and induce apoptosis of hepatocellular carcinoma cells by
Chao JC1, Chiang SW, Wang CC, Tsai YH, Wu MS.(PubMed)
(1733) Oriental medicine Kyung-Ok-Ko prevents and alleviates
dehydroepiandrosterone-induced polycystic ovarian syndrome in rats by Jang M1,
Lee MJ1, Lee JM2, Bae CS3, Kim SH4, Ryu JH5, Cho IH6.(PubMed)
(1734) Catalpol decreases peroxynitrite formation and consequently
exerts cardioprotective effects against ischemia/reperfusion insult byHuang C1,
Cui Y, Ji L, Zhang W, Li R, Ma L, Xing W, Zhou H, Chen B, Yu J, Zhang H.(PubMed)
(1735) Saeng-Ji-Hwang has a protective effect on
adriamycin-induced cytotoxicity in cardiac muscle cells by Chae HJ1, Kim HR,
Kim DS, Woo ER, Cho YG, Chae SW.(PubMed)
(1736) [Effect of dandi tablet on blood lipids and sex hormones in
women of postmenopausal stage]. [Article in Chinese] by Liang R1, Chen MR, Xu
X.(PubMed)
(1737) Rehmannia glutinosa (Gaertn.) DC. polysaccharide
ameliorates hyperglycemia, hyperlipemia and vascular inflammation in
streptozotocin-induced diabetic mice by Zhou J1, Xu G2, Yan J2, Li K2, Bai Z2,
Cheng W2, Huang K3.(PubMed)
(1738) Oriental medicine Kyung-Ok-Ko prevents and alleviates
dehydroepiandrosterone-induced polycystic ovarian syndrome in rats by Jang M1,
Lee MJ1, Lee JM2, Bae CS3, Kim SH4, Ryu JH5, Cho IH6.(PubMed)
(1739) Antidiabetic Effects of Carassius auratus Complex Formula
in High Fat Diet Combined Streptozotocin-Induced Diabetic Mice by Wang ZH1, Hsu
CC2, Lin HH3, Chen JH2.(PubMed)
(1740) Ameliorating effect and potential mechanism of Rehmannia
glutinosa oligosaccharides on the impaired glucose metabolism in chronic stress
rats fed with high-fat diet by Zhang R1, Zhou J2, Li M2, Ma H3, Qiu J2, Luo X4,
Jia Z5.(PubMed)
(1741) d-galactose administration induces memory loss and energy
metabolism disturbance in mice: protective effects of catalpol by Zhang XL1, An
LJ, Bao YM, Wang JY, Jiang B.(PubMed)
(1742) Rehmannia inhibits adipocyte differentiation and
adipogenesis by Jiang L1, Zhang NX, Mo W, Wan R, Ma CG, Li X, Gu YL, Yang XY,
Tang QQ, Song HY.(PubMed)
(1743) The effect of a traditional Chinese prescription for a case
of lung carcinoma by Kamei T1, Kumano H, Iwata K, Nariai Y, Matsumoto T.(PubMed)
(1744) The effects of the standardized herbal formula PM014 on
pulmonary inflammation and airway responsiveness in a murine model of cockroach
allergen-induced asthma by Jung KH1, Choi HL2, Park S3, Lee G4, Kim M5, Min
JK6, Min BI7, Bae H8.(PubMed)
(1745) [Shengdi injection on rat model of lung inflammation
induced by lipopolysaccharides]. [Article in Chinese] by Liu L1, Tang L, Xu DS,
Xia HL, Xie QM.(PubMed)
(1746) The effects of the standardized herbal formula PM014 on
pulmonary inflammation and airway responsiveness in a murine model of cockroach
allergen-induced asthma by Jung KH1, Choi HL2, Park S3, Lee G4, Kim M5, Min
JK6, Min BI7, Bae H8.(PubMed)
(1747) Rehmannia glutinosa activates intracellular antioxidant
enzyme systems in mouse auditory cells by Yu HH1, Kim YH, Jung SY, Shin MK,
Park RK, So HS, Kim KY, Lee DH, You YO.(PubMed)
(1748) Lycium barbarum polysaccharides induce apoptosis in human
prostate cancer cells and inhibits prostate cancer growth in a xenograft mouse
model of human prostate cancer by Luo Q1, Li Z, Yan J, Zhu F, Xu RJ, Cai YZ.(PubMed)
(1749) [Observation of the effects of LAK/IL-2 therapy combining
with Lycium barbarum polysaccharides in the treatment of 75 cancer patients].
[Article in Chinese] by Cao GW1, Yang WG, Du P.(PubMed)
(1750) Lycium barbarum inhibits growth of estrogen receptor
positive human breast cancer cells by favorably altering estradiol metabolism
by Li G1, Sepkovic DW, Bradlow HL, Telang NT, Wong GY.(PubMed)
(1751) An evidence-based update on the pharmacological activities
and possible molecular targets of Lycium barbarum polysaccharides by Cheng J1,
Zhou ZW2, Sheng HP3, He LJ4, Fan XW5, He ZX6, Sun T7, Zhang X8, Zhao RJ9, Gu
L10, Cao C2, Zhou SF11.(PubMed)
(1752) Lycium barbarum polysaccharides prevent memory and
neurogenesis impairments in scopolamine-treated rats by Chen W1, Cheng X2, Chen
J3, Yi X2, Nie D4, Sun X5, Qin J2, Tian M2, Jin G2, Zhang X2.(PubMed)
(1753) [Effects of lycium barbarum polysaccharide on formation of
traumatic neuroma and pain after transection of sciatic nerve in rats].
[Article in Chinese] by Fan H1, Deng C, Fu J, Ding L, Yin G, Ma Y.(PubMed)
(1754) Lycium (Lycium barbarum) by Cassileth B1.(PubMed)
(1755) Goji berry effects on macular characteristics and plasma
antioxidant levels by Bucheli P1, Vidal K, Shen L, Gu Z, Zhang C, Miller LE,
Wang J.(PubMed)
(1756) Anti-diabetic effects of the ethanol extract of a
functional formula diet in mice fed with a fructose/fat-rich combination diet
by Cheng Q1, Zhang X, Wang O, Liu J, Cai S, Wang R, Zhou F, Ji B.(PubMed)
(1757) Comparative evaluation of the antioxidant effects of the
natural vitamin C analog 2-O-β-D-glucopyranosyl-L-ascorbic acid isolated from
Goji berry fruit by Zhang Z1, Liu X, Zhang X, Liu J, Hao Y, Yang X, Wang Y.(PubMed)
(1758) Qi Zi(Complementary
and Alternative Healing University)
(1760) A diet formula of Puerariae radix, Lycium barbarum,
Crataegus pinnatifida, and Polygonati rhizoma alleviates insulin resistance and
hepatic steatosis in CD-1 mice and HepG2 cellsby Liu J1, Zhang H, Ji B, Cai S,
Wang R, Zhou F, Yang J, Liu H.(PubMed)
(1761) Dietary Lycium barbarum polysaccharide induces Nrf2/ARE
pathway and ameliorates insulin resistance induced by high-fat via activation
of PI3K/AKT signaling by Yang Y1, Li W2, Li Y2, Wang Q2, Gao L3, Zhao J4.(PubMed)
(1762) Lycium barbarum (goji) juice improves in vivo antioxidant
biomarkers in serum of healthy adults by Amagase H1, Sun B, Borek C.(PubMed)
(1763) Effect of drying methods on physicochemical properties and
antioxidant activities of wolfberry (Lycium barbarum) polysaccharide by Zhao
Q1, Dong B2, Chen J2, Zhao B3, Wang X1, Wang L1, Zha S4, Wang Y1, Zhang J5,
Wang Y5.(PubMed)
(1764) Anti-inflammatory effect of Lycii radicis in LPS-stimulated
RAW 264.7 macrophages by Song MY1, Jung HW, Kang SY, Kim KH, Park YK.(PubMed)
(1765) Anti-inflammatory effect of Lycium Fruit water extract in
lipopolysaccharide-stimulated RAW 264.7 macrophage cells by Oh YC1, Cho WK, Im
GY, Jeong YH, Hwang YH, Liang C, Ma JY.(PubMed)
(1766) Metabolic Signatures of Kidney Yang Deficiency Syndrome and
Protective Effects of Two Herbal Extracts in Rats Using GC/TOF by MS. Zhao L1,
Wu H, Qiu M, Sun W, Wei R, Zheng X, Yang Y, Xin X, Zou H, Chen T, Liu J, Lu L,
Su J, Ma C, Zhao A, Jia W.(PubMed)
(1767) Synaptic plasticity, but not hippocampal neurogenesis,
mediated the counteractive effect of wolfberry on depression in rats(1) by
Zhang E1, Yau SY, Lau BW, Ma H, Lee TM, Chang RC, So KF.(PubMed)
(1768) A meta-analysis of clinical improvements of general
well-being by a standardized Lycium barbarum by Paul Hsu CH1, Nance DM, Amagase
H.(PubMed)
(1769) Evaluation of hypoglycemic activity of the polysaccharides
extracted from Lycium barbarum by Jing L1, Cui G, Feng Q, Xiao Y.(PubMed)
(1770) Hypoglycemic effects and mechanisms of action of Cortex
Lycii Radicis on alloxan-induced diabetic mice by Gao D1, Li Q, Liu Z, Li Y,
Liu Z, Fan Y, Li K, Han Z, Li J.(PubMed)
(1771) Protection of retinal ganglion cells and retinal
vasculature by Lycium barbarum polysaccharides in a mouse model of acute ocular
hypertension by Mi XS1, Feng Q, Lo AC, Chang RC, Lin B, Chung SK, So KF.(PubMed)
(1772) Goji (Lycium barbarum and L. chinense): Phytochemistry,
pharmacology and safety in the perspective of traditional uses and recent
popularity by Potterat O1.(PubMed)
(1773) Effects of Lycium barbarum polysaccharides on oxidative
stress in hyperlipidemic mice following chronic composite psychological stress
intervention by Zhu X1, Hu S1, Zhu L1, Ding J1, Zhou Y1, Li G1.(PubMed)
(1774) Hypoglycemic and hypolipidemic effects and antioxidant
activity of fruit extracts from Lycium barbarum by Luo Q1, Cai Y, Yan J, Sun M,
Corke H..(PubMed)
(1775) Practical Application of Antidiabetic Efficacy of Lycium
barbarum Polysaccharide in Patients with Type 2 Diabetes by Cai H, Liu F, Zuo
P, Huang G, Song Z, Wang T, Lu H, Guo F, Han C, Sun G1.(PubMed)
(1776) Characterization and hypoglycemic effect of a
polysaccharide extracted from the fruit of Lycium barbarum L. by Zhu J1, Liu W,
Yu J, Zou S, Wang J, Yao W, Gao X.(PubMed)
(1777) Lycium barbarum polysaccharides reduce intestinal
ischemia/reperfusion injuries in rats by Yang X1, Bai H, Cai W, Li J, Zhou Q,
Wang Y, Han J, Zhu X, Dong M, Hu D.(PubMed)
(1778) [Effect of Lycium ruthenicum anthocyanins on
atherosclerosis in mice]. [Article in Chinese] by Lin L1, Li J, Lv H, Ma Y,
Qian Y.(PubMed)(1779)
Chinese Herbs – Ren Shen (Radix Ginseng) by Kyle
J. Norton
(1780) ren shen (ginseng)(Complementary and Alternative
Healing University)
(1781) Ginseng, the 'Immunity Boost': The Effects of Panax ginseng
on Immune System by Kang S1, Min H.(PubMed)
(1782) [Comparative study of main components of ginseng on immune
function of rats]. [Article in Chinese] by Jia ZY, Xie X, Wang XY, Jia W.(PubMed)
(1783) Ginsenoside Rp1 from Panax ginseng exhibits anti-cancer
activity by down-regulation of the IGF-1R/Akt pathway in breast cancer cells by
Kang JH1, Song KH, Woo JK, Park MH, Rhee MH, Choi C, Oh SH.(PubMed)
(1784) In vitro anti-cancer activity and structure-activity
relationships of natural products isolated from fruits of Panax ginseng by Wang
W1, Zhao Y, Rayburn ER, Hill DL, Wang H, Zhang R.(PubMed)
(1785) Pharmacokinetics and tissue distribution of
25-hydroxyprotopanaxadiol, an anti-cancer compound isolated from Panax ginseng,
in athymic mice bearing xenografts of human pancreatic tumors by Hao M1, Wang
W, Zhao Y, Zhang R, Wang H.(PubMed)
(1786) Ginsenoside Rg1 prevents cognitive impairment and
hippocampus senescence in a rat model of D-galactose-induced aging. Zhu J1, Mu
X1, Zeng J2, Xu C1, Liu J1, Zhang M1, Li C1, Chen J3, Li T3, Wang Y1.(PubMed)
(1787) [Research of anti-aging mechanism of ginsenoside Rg1 on
brain]. [Article in Chinese] by Li CP, Zhang MS, Liu J, Geng S, Li J, Zhu JH,
Zhang YY, Jia YY, Wang L, Wang SH, Wang YP.(PubMed)
(1788) Anti-stress effects of Ginkgo biloba and Panax ginseng: a
comparative study by Rai D1, Bhatia G, Sen T, Palit G.(PubMed)
(1789) [The anti-stress effect of saponins extracted from panax
ginseng fruit and the hypophyseal-adrenal system (author's transl)]. [Article
in Chinese] by Zhang SC, Jiang XL.(PubMed)
(1790) Antioxidant effects of Panax ginseng C.A. Meyer in healthy
subjects: a randomized, placebo-controlled clinical trial by Kim HG1, Yoo SR,
Park HJ, Lee NH, Shin JW, Sathyanath R, Cho JH, Son CG.(PubMed)
(1791) Panax ginseng reduces oxidative stress and restores
antioxidant capacity in aged rats by Ramesh T1, Kim SW, Hwang SY, Sohn SH, Yoo
SK, Kim SK.(PubMed)
(1792) Panax ginseng C.A. Mayer G115 modulates pro-inflammatory
cytokine production in mice throughout the increase of macrophage toll-like
receptor 4 expression during physical stress by Pannacci M1, Lucini V, Colleoni
F, Martucci C, Grosso S, Sacerdote P, Scaglione F.(PubMed)
(1793) Panax Potential analgesic and anti-inflammatory activities
of Panax ginseng head butanolic fraction in animals by Lee JH1, Lee JH, Lee YM,
Kim PN, Jeong CS.(PubMed)
(1794) Treatment with ginseng total saponins improves the
neurorestoration of rat after traumatic brain injury by Hu BY1, Liu XJ2, Qiang
R3, Jiang ZL4, Xu LH1, Wang GH1, Li X1, Peng B1.(PubMed)
(1795) [Advance in studies of Panax notoginseng saponins on
pharmacological mechanism of nervous system disease]. [Article in Chinese] by
Su P, Wang L, Du SJ, Xin WF, Zhang WS.(PubMed)
(1796) Neuroprotective effect of pseudoginsenoside-f11 on a rat
model of Parkinson's disease induced by 6-hydroxydopamine by Wang JY1, Yang
JY1, Wang F1, Fu SY1, Hou Y1, Jiang B1, Ma J1, Song C1, Wu CF1.(PubMed)
(1797) The haematopoietic effect of Panax japonicus on blood
deficiency model mice by Zhang H1, Wang HF2, Liu Y3, Huang LJ3, Wang ZF4, Li
Y5.(PubMed)
(1798) [Effect of Panax notoginsenosides on the proliferation of
hematopoietic progenitor cells in mice with immune-mediated aplastic anemia].
[Article in Chinese] by Gai Y1, Gao RL, Niu YP.(PubMed)
(1799) Korean
ginseng-induced occupational asthma and determination of IgE binding components
by Kim KM1, Kwon HS, Jeon SG, Park CH, Sohn SW, Kim DI, Kim SS, Chang YS, Kim
YK, Cho SH, Min KU, Kim YY.(PubMed)
(1800) [Acute massive pulmonary embolism in a patient using clavis
panax]. [Article in Turkish] by Yüksel IO1, Arslan S, Cağırcı G, Yılmaz A.(PubMed)
(1801) Effect of Memo®, a natural formula combination, on
Mini-Mental State Examination scores in patients with mild cognitive impairment
by Yakoot M1, Salem
(1802) Evaluation of the ergogenic properties of ginseng: an update
by Bahrke MS1, Morgan WR.(PubMed)
(1803) [Treatment with carnitine, acetyl carnitine, L-arginine and
ginseng improves sperm motility and sexual health in men with asthenopermia].
[Article in Italian] by Morgante G1, Scolaro V, Tosti C, Di Sabatino A,
Piomboni P, De Leo V.(PubMed)
(1804) Effects of Korean red ginseng on sexual arousal in
menopausal women: placebo-controlled, double-blind crossover clinical study by
Oh KJ1, Chae MJ, Lee HS, Hong HD, Park K.(PubMed)
(1805) Antifatigue effects of Panax ginseng C.A. Meyer: a
randomised, double-blind, placebo-controlled trial by Kim HG1, Cho JH, Yoo SR,
Lee JS, Han JM, Lee NH, Ahn YC, Son CG.(PubMed)
(1806) High-Dose Asian Ginseng (Panax Ginseng) for Cancer-Related
Fatigue: A Preliminary Report by Yennurajalingam S1, Reddy A2, Tannir NM3,
Chisholm GB4, Lee RT5, Lopez G5, Escalante CP6, Manzullo EF6, Frisbee Hume S2,
Williams JL2, Cohen L5, Bruera E2.(PubMed)
(1807) 16 cases of coronary angina pectoris treated with powder
composed of radix ginseng, radix notoginseng and succinum by Yuan J1, Guo W,
Yang B, Liu P, Wang Q, Yuan H.(PubMed)
(1808) Effects of Korean red ginseng extract on cisplatin-induced
nausea and vomiting by Kim JH1, Yoon IS, Lee BH, Choi SH, Lee JH, Lee JH, Jeong
SM, Kim SC, Park CK, Lee SM, Nah SY.(PubMed)
(1809) Effects of Korean Red Ginseng on Cardiovascular Risks in
Subjects with Metabolic Syndrome: a Double-blind Randomized Controlled Study by
Park BJ1, Lee YJ, Lee HR, Jung DH, Na HY, Kim HB, Shim JY.(PubMed)
(1810) Vinegar-processed ginseng radix improves metabolic syndrome
induced by a high fat diet in ICR mice by Yun SN1, Ko SK
(1811) Traditional chinese medicine in treatment of metabolic
syndrome by Yin J1, Zhang H, Ye J.(PubMed)
(1812) Amelioration of insulin resistance by Rk1 + Rg5 complex
under endoplasmic reticulum stress conditions by Ponnuraj SP1, Siraj F1, Kang
S1, Noh HY1, Min JW1, Kim YJ1, Yang DC1.(PubMed)
(1813) Improvement of insulin resistance by panax ginseng in
fructose-rich chow-fed rats by Liu TP1, Liu IM, Cheng JT.(PubMed)
(1814) The effect of ginseng (the genus panax) on glycemic
control: a systematic review and meta-analysis of randomized controlled
clinical trials by Shishtar E1, Sievenpiper JL2, Djedovic V1, Cozma AI1, Ha V1,
Jayalath VH1, Jenkins DJ3, Meija SB1, de Souza RJ4, Jovanovski E1, Vuksan V3.(PubMed)
(1815) Postprandial glucose-lowering effects of fermented red
ginseng in subjects with impaired fasting glucose or type 2 diabetes: a
randomized, double-blind, placebo-controlled clinical trial by Oh MR, Park SH,
Kim SY, Back HI, Kim MG, Jeon JY, Ha KC, Na WT, Cha YS, Park BH, Park TS1, Chae
SW.(PubMed)
(1816) Anti-hyperglycemic effect of fermented ginseng in type 2
diabetes mellitus mouse model by Jeon WJ1, Oh JS, Park MS, Ji GE.(PubMed)
(1817) Anti-hyperglycemic effects of ginseng: comparison between
root and berry by Dey L1, Xie JT, Wang A, Wu J, Maleckar SA, Yuan CS.(PubMed)
(1818) Anti-atherogenic action of panax ginseng in rats and in
patients with hyperlipidemia by Yamamoto M1, Kumagai A.(PubMed)
(1819) Serum HDL-cholesterol-increasing and fatty liver-improving
actions of Panax ginseng in high cholesterol diet-fed rats with clinical effect
on hyperlipidemia in man by Yamamoto M, Uemura T, Nakama S, Uemiya M, Kumagai
A.(PubMed)
(1820) Orally administered ginseng extract reduces serum total
cholesterol and triglycerides that induce fatty liver in 66% hepatectomized
rats by Cui X1, Sakaguchi T, Ishizuka D, Tsukada K, Hatakeyama K.(PubMed)
(1821) Effect of panax notoginseng saponins injection on the
p38MAPK pathway in lung tissue in a rat model of hypoxic pulmonary hypertension
by Zhao S1, Zheng MX, Chen HE, Wu CY, Wang WT.(PubMed)
(1822) Negligible pharmacokinetic interaction of red ginseng and
antihypertensive agent amlodipine in Sprague-Dawley rats by Ryu SH1, Kim JW,
Kim YS, Lee SH, Cho YB, Lee HK, Kim YG, Jeong WS, Kim KB.(PubMed)
(1823) Effect of ginsam, a vinegar extract from Panax ginseng, on
body weight and glucose homeostasis in an obese insulin-resistant rat model by
Lim S1, Yoon JW, Choi SH, Cho BJ, Kim JT, Chang HS, Park HS, Park KS, Lee HK,
Kim YB, Jang HC.(PubMed)
(1824) Weight gain reduction in mice fed Panax ginseng saponin, a
pancreatic lipase inhibitor by Karu N1, Reifen R, Kerem Z.(PubMed)
(1825) Anti-obesity effects of chikusetsusaponins isolated from
Panax japonicus rhizomes by Han LK1, Zheng YN, Yoshikawa M, Okuda H, Kimura Y.(PubMed)
(1826) Korean red ginseng (Panax ginseng) improves insulin
sensitivity and attenuates the development of diabetes in Otsuka Long-Evans
Tokushima fatty rats by Lee HJ1, Lee YH, Park SK, Kang ES, Kim HJ, Lee YC, Choi
CS, Park SE, Ahn CW, Cha BS, Lee KW, Kim KS, Lim SK, Lee HC.(PubMed)
(1827) Ginseng modifies the diabetic phenotype and genes
associated with diabetes in the male ZDF rat by Banz WJ1, Iqbal MJ, Bollaert M,
Chickris N, James B, Higginbotham DA, Peterson R, Murphy L.(PubMed)
(1828) Antidiabetic effects of malonyl ginsenosides from Panax
ginseng on type 2 diabetic rats induced by high-fat diet and streptozotocin by
Liu Z1, Li W, Li X, Zhang M, Chen L, Zheng YN, Sun GZ, Ruan CC.(PubMed)
(1829) Ginseng extracts restore high-glucose induced vascular
dysfunctions by altering triglyceride metabolism and downregulation of
atherosclerosis-related genes by Chan GH1, Law BY, Chu JM, Yue KK, Jiang ZH,
Lau CW, Huang Y, Chan SW, Ying-Kit Yue P, Wong RN.(PubMed)
(1830) Merit of ginseng in the treatment of heart failure in type
1-like diabetic rats by Tsai CC1, Chan P2, Chen LJ3, Chang CK4, Liu Z5, Lin
JW4.(PubMed)
(1831) Ginseng is useful to enhance cardiac contractility in
animals by Lin JW1, Cherng YG2, Chen LJ3, Niu HS4, Chang CK1, Niu CS4.(PubMed)(1832) Herbal
Ginseng and Infertility by Kyle
J. Norton.
(1832 1833)
(1834) Schisphenlignans A-E: five new dibenzocyclooctadiene
lignans from Schisandra sphenanthera by Liang CQ1, Hu J, Shi YM, Shang SZ, Du
X, Zhan R, Xiong WY, Zhang HB, Xiao WL, Sun HD.(PubMed)
(1835) Six new lignans from the leaves and stems of Schisandra
sphenantheraby Liang CQ1, Hu J, Luo RH, Shi YM, Shang SZ, Gao ZH, Wang RR,
Zheng YT, Xiong WY, Zhang HB, Xiao WL, Sun HD.(PubMed)
(1936) Dietary pulp from Fructus Schisandra Chinensis
supplementation reduces serum/hepatic lipid and hepatic glucose levels in mice
fed a normal or high cholesterol/bile salt diet by Sun N, Pan SY1, Zhang Y,
Wang XY, Zhu PL
(1937) Dietary Fructus Schisandrae extracts and fenofibrate
regulate the serum/hepatic lipid-profile in normal and hypercholesterolemic
mice, with attention to hepatotoxicity by Pan SY1, Yu Q, Zhang Y, Wang XY, Sun
N, Yu ZL, Ko KM.(PubMed)
(1838) Cardioprotective effects of aqueous Schizandra chinensis
fruit extract on ovariectomized and balloon-induced carotid artery injury rat
models: effects on serum lipid profiles and blood pressure. Kim EY1, Baek IH,
Rhyu MR.(PubMed)
(1839) Therapeutic potential of Schisandra chinensis extracts for
treatment of hypertension. Introduction to: 'antihypertensive effect of gomisin
A from Schisandra chinensis on angiotensin II-induced hypertension via
preservation of nitric oxide bioavailability' by Park et al. Alexander JS1,
Wang Y.(PubMed)
(1840) Fatty acid synthase inhibitory activity of
dibenzocyclooctadiene lignans isolated from Schisandra chinensis by Na M1, Hung
TM, Oh WK, Min BS, Lee SH, Bae K.(PubMed)
(1841) The high throughput screening of neuropeptide FF2 receptor
ligands from Korean herbal plant extracts by Do EU1, Piao LZ, Choi G, Choi YB,
Kang TM, Shin J, Chang YJ, Nam HY, Kim HJ, Kim SI.(PubMed)
(1842) [Effects of fructus schisandrae on the function of the
pituitary-testis axis and carbohydrate metabolism in rats undergoing
experimental navigation and high-intensity exercise]. [Article in Chinese] by
Xia P1, Sun LJ, Wang J.(PubMed)
(1843) The beneficial effects of combined grape pomace and omija
fruit extracts on hyperglycemia, adiposity and hepatic steatosis in db/db mice:
a comparison with major index compounds by Cho SJ1, Park HJ1, Jung UJ2, Kim
HJ3, Moon BS4, Choi MS5.(PubMed)
(1844)Antidiabetic Effect of Schisandrae Chinensis Fructus
Involves Inhibition of the Sodium Glucose Cotransporter by Qu Y1, Chan JY, Wong
CW, Cheng L, Xu C, Leung AW, Lau CB.(PubMed)
(1845) Advanced glycation end-products inhibitors isolated from
Schisandra grandiflora by Poornima B1, Anand Kumar D, Siva B, Venkanna A,
Vadaparthi PR, Kumar K, Tiwari AK, Suresh Babu K.(PubMed)
(1846) The protective effects of Schisandra chinensis fruit
extract and its lignans against cardiovascular disease: a review of the
molecular mechanisms by Chun JN1, Cho M2, So I3, Jeon JH4.(PubMed)
(1847) Beneficial effects of schisandrin B on the cardiac function
in mice model of myocardial infarction by Chen P1, Pang S, Yang N, Meng H, Liu
J, Zhou N, Zhang M, Xu Z, Gao W, Chen B, Tao Z, Wang L, Yang Z.(PubMed)
1848) ontrolled trail on moxibustion for maintenance hemodialysis
patients in deficiency syndrome]. [Article in Chinese] Li N1, Qiu MY, Hao JR,
Zhang QM, Wang SH, Liang F, Yin Y, Luan J, Ge GZ, Qin T, Li BQ.(PubMed)
(1849) [Observation on therapeutic effect of the new Bianshi
(stone needle) therapy on migraine]. [Article in Chinese] Yin ZJ1, Yan YJ, Bao
HL(PubMed)
(1850) [Study on relation of kidney-deficiency with hearing damage
and serum trace elements in patients with chronic nephropathy]. [Article in
Chinese] by Yu J1, Xu Y, Fu XD.(PubMed)
(1851) [A family survey of syndromes of traditional Chinese
medicine in patients with beta-thalassemia]. [Article in Chinese] by Wang WJ1,
Wu ZK, Zhang XH, Liu WJ, Liu YM, Fang SP, Wang RX, Zhang C, Li PP, Luo RG.(PubMed)
(1852) The clinical experiences of Dr. CAI Gan in treating chronic
constipation by Zhang ZL1, Zhu MP, Liu Q, Lei YX.(PubMed)
(1853) [Analysis of 35 cases of pathology in yin deficiency
syndrome]. [Article in Chinese] by Dai HL, Chen ZL, Song QL.(PubMed)
(1854) Liuwei Dihuang decoction facilitates the induction of
long-term potentiation (LTP) in senescence accelerated mouse/prone 8 (SAMP8)
hippocampal slices by inhibiting voltage-dependent calcium channels (VDCCs) and
promoting N-methyl-d-aspartate receptor (NMDA) receptors by Huang Y1, Zhang H,
Yang S, Qiao H, Zhou W, Zhang Y.(PubMed)
(1855) Diagnosis of symptomatic postmenopausal women by
traditional Chinese medicine practitioners by Zell B1, Hirata J, Marcus A,
Ettinger B, Pressman A, Ettinger KM.(PubMed)
(1856) An integrated metabonomic and proteomic study on Kidney-Yin
Deficiency Syndrome patients with diabetes mellitus in China by Jiang N1, Liu
HF2, Li SD1, Zhou WX1, Zhang YX1, Zhang Q3, Yan XZ3.(PubMed)
(1857) [Preliminary study on relationship of
disease-syndrome-symptom of ovulatory disorder infertility based on factor
analysis]. [Article in Chinese] by Li M, Ma K, Shan J.(PubMed)
(1858) Traditional chinese medicine syndromes for essential
hypertension: a literature analysis of 13,272 patients by Wang J1, Xiong X1,
Liu W1.(PubMed)
(1859) [Clinical observation on treatment of hyperinsulinemia and
hyperandrogenism anovulatory patient with replenishing kidney-yin drugs].
[Article in Chinese] by Zhou LR1, Yu J.(PubMed)
(1860)
(1862) Low-Molecular-Weight Peptides from Salmon Protein Prevent
Obesity-Linked Glucose Intolerance, Inflammation and Dyslipidemia in
LDLR-/-/ApoB100/100 Mice by Chevrier G1, Mitchell PL1, Rioux LE1, Hasan F2, Jin
T2, Roblet CR3, Doyen A3, Pilon G1, St-Pierre P1, Lavigne C1, Bazinet L3,
Jacques H3, Gill T2, McLeod RS4, Marette A5.(PubMed)
(1863) Interdependency of selected metabolic variables in an
animal model of metabolic syndrome by Mellouk Z1, Sener A2, Yahia DA1, Malaisse
WJ2.(PubMed)
(1864) Lower prevalence of impaired glucose tolerance and diabetes
associated with daily seal oil or salmon consumption among Alaska Natives by
Adler AI1, Boyko EJ, Schraer CD, Murphy NJ.(PubMed)
(1865) Differential effects of various fish proteins in altering
body weight, adiposity, inflammatory status, and insulin sensitivity in
high-fat-fed rats by Pilon G1, Ruzzin J, Rioux LE, Lavigne C, White PJ,
Frøyland L, Jacques H, Bryl P, Beaulieu L, Marette A.(PubMed)
(1866) Oral salmon calcitonin protects against impaired fasting
glycemia, glucose intolerance, and obesity induced by high-fat diet and
ovariectomy in rats by Feigh M1, Andreassen KV, Hjuler ST, Nielsen RH,
Christiansen C, Henriksen K, Karsdal MA.(PubMed)
(1867) Daily rhythms in expression of genes of hepatic lipid metabolism
in Atlantic salmon (Salmo salar L.) by Betancor MB1, McStay E1, Minghetti M1,
Migaud H1, Tocher DR1, Davie A1.(PubMed)
(1868) Inhibition by salmon calcitonin (SCT) of
desoxycorticosterone acetate (DOCA) induced hypertension in the rat by Aldred
JP, Luna PD, Zeedyk RA, Bastian JW.(PubMed)
(1869) Moderate consumption of fatty fish reduces diastolic blood
pressure in overweight and obese European young adults during energy
restriction by Ramel A1, Martinez JA, Kiely M, Bandarra NM Thorsdottir I.
(1870) A salmon protein hydrolysate exerts lipid-independent
anti-atherosclerotic activity in ApoE-deficient mice by Parolini C1, Vik R2,
Busnelli M1, Bjørndal B2, Holm S3, Brattelid T4, Manzini S1, Ganzetti GS1,
Dellera F1, Halvorsen B3, Aukrust P3, Sirtori CR1, Nordrehaug JE5, Skorve J2,
Berge RK6, Chiesa G1.(PubMed)
(1871) Relationship between dietary pattern and cognitive function
in elderly patients with type 2 diabetes mellitus by Enomoto M1, Yoshii H2,
Mita T3, Sanke H4, Yokota A1, Yamashiro K1, Inagaki N1, Gosho M5, Ohmura C4,
Kudo K6, Watada H7, Onuma T1.(PubMed)
(1872) Coronary changes in the Atlantic salmon Salmo salar L:
characterization and impact of dietary fatty acid compositions by Dalum A1,
Tangen R, Falk K, Hordvik I, Rosenlund G, Torstensen B, Koppang EO.(PubMed)
(1874) Genetically modified plants: Global Cultivation Area
Soybean(GMO
compass)
(1875) Effect of soy nuts and equol status on blood pressure,
lipids and inflammation in postmenopausal women stratified by metabolic
syndrome status by Acharjee S1, Zhou JR2, Elajami TK1, Welty FK3.(PubMed)
(1876) Partly replacing meat protein with soy protein alters
insulin resistance and blood lipids in postmenopausal women with abdominal
obesity by van Nielen M1, Feskens EJ1, Rietman A1, Siebelink E1, Mensink M2.(PubMed)
(1877) Effect of soy protein from differently processed products
on cardiovascular disease risk factors and vascular endothelial function in
hypercholesterolemic subject by Matthan NR1, Jalbert SM, Ausman LM, Kuvin JT,
Karas RH, Lichtenstein AH.(PubMed)
(1878) The effects of a diet formulation with oats, soybeans, and
flax on lipid profiles and uricemia in patients with AIDS and dyslipidemia by
Ferreira Rdos S1, Cassaro DC2, Domingos H3, Pontes ER4, Aiko PH4, Meira JE5.(PubMed)
(1879) Dietary patterns and cardiovascular disease-related risks
in chinese older adults by Sun J1, Buys N1, Shen S2.(PubMed)
(1880) A meal replacement regimen improves blood glucose levels in
prediabetic healthy individuals with impaired fasting glucose by König D1,
Kookhan S2, Schaffner D2, Deibert P3, Berg A2.(PubMed)
(1881) Oral administration of soybean peptide Vglycin normalizes
fasting glucose and restores impaired pancreatic function in Type 2 diabetic
Wistar rats by Jiang H1, Feng J2, Du Z1, Zhen H3, Lin M2, Jia S4, Li T5, Huang
X6, Ostenson CG7, Chen Z8.(PubMed)
(1882) Opposite effects of genistein on the regulation of
insulin-mediated glucose homeostasis in adipose tissue. Wang M1, Gao XJ, Zhao
WW, Zhao WJ, Jiang CH, Huang F, Kou JP, Liu BL, Liu K.(PubMed)
(1883) Dietary isoflavone intake is associated with evoked
responses to inflammatory cardiometabolic stimuli and improved glucose
homeostasis in healthy volunteers by Ferguson JF1, Ryan MF2, Gibney ER2,
Brennan L2, Roche HM3, Reilly MP4.(PubMed)
(1884) The beneficial effect of soybean (Glycine max (L.) Merr.)
leaf extracts in adults with prediabetes: a randomized placebo controlled trial
by Choi MS1, Ryu R, Seo YR, Jeong TS, Shin DH, Park YB, Kim SR, Jung UJ.(PubMed)
(1885)Equol producers can have low leptin levels among prediabetic
and diabetic females by Sakane N1, Kotani K2, Tsuzaki K3, Takahashi K4, Usui
T5, Uchiyama S6, Fujiwara S7.(PubMed)
(1886) Obesity prevalence in relation to gut microbial
environments capable of producing equol or O-desmethylangolensin from the
isoflavone daidzein by Frankenfeld CL1, Atkinson C2, Wähälä K3, Lampe JW4.(PubMed)
(1887) Effect of soy product kinako and fish oil on serum lipids
and glucose metabolism in women with metabolic syndrome by Simão AN1, Lozovoy
MA, Dichi I.
(1888) Appetite control and biomarkers of satiety with vegetarian
(soy) and meat-based high-protein diets for weight loss in obese men: a
randomized crossover trial by Neacsu M1, Fyfe C1, Horgan G1, Johnstone AM1.(PubMed)
(1889) Soy fiber improves weight loss and lipid profile in overweight
and obese adults: a randomized controlled trial by Hu X1, Gao J, Zhang Q, Fu Y,
Li K, Zhu S, Li D.(PubMed)
(1890) Effects of soya oligosaccharides and soya oligopeptides on
lipid metabolism in hyperlipidaemic rats by Xie S1, Zhu J, Zhang Y, Shi K, Shi
Y, Ma X.(PubMed)
(1891) Effects of dietary plant meal and soya-saponin
supplementation on intestinal and hepatic lipid droplet accumulation,
lipoprotein and sterol metabolism in Atlantic salmon (Salmo salar L.) -
CORRIGENDUM. Gu M, Kortner TM, Penn M, Hansen AK
(1892) Soy food consumption, cardiometabolic alterations and
carotid intima-media thickness in Chinese adults by Liu J1, Sun LL1, He LP2,
Ling WH1, Liu ZM3, Chen YM4.(PubMed)
(1893) Soy-isoflavone-enriched foods and markers of lipid and
glucose metabolism in postmenopausal women: interactions with genotype and
equol production by Hall WL1, Vafeiadou K, Hallund J, Bugel S, Reimann M,
Koebnick C, Zunft HJ, Ferrari M, Branca F, Dadd T, Talbot D, Powell J, Minihane
AM, Cassidy A, Nilsson M, Dahlman-Wright K, Gustafsson JA, Williams CM.(PubMed)
(1895) Medicinal mushroom science: Current perspectives, advances,
evidences, and challenges by Wasser SP1.(PubMed)
(1896) Current findings, future trends, and unsolved problems in
studies of medicinal mushrooms by Wasser SP1.(PubMed)
(1897) The role of culinary-medicinal mushrooms on human welfare
with a pyramid model for human health by Chang ST1, Wasser SP.(PubMed)
(1898) Positive effect of mushrooms substituted for meat on body
weight, body composition, and health parameters. A 1-year randomized clinical
trial. Poddar KH1, Ames
(1899) White vegetables: glycemia and satiety by Anderson GH1,
Soeandy CD, Smith CE.(PubMed)
(1900) Suppression of inflammatory and allergic responses by
pharmacologically potent fungus Ganoderma lucidum by Bhardwaj N, Katyal P,
Sharma AK1.(PubMed)
(1901) Edible mushrooms: improving human health and promoting
quality life by Valverde ME1, Hernández-Pérez T1, Paredes-López O1.(PubMed)
(1902) Mushrooms: a potential natural source of anti-inflammatory
compounds for medical applications by Elsayed EA1, El Enshasy H2, Wadaan MA3,
Aziz R4.(PubMed)
(1903) Anticancer and antimicrobial activities and chemical
composition of the birch mazegill mushroom Lenzites betulina (higher
Basidiomycetes) by Liu K1, Wang JL2, Zhao L2, Wang Q2.(PubMed)
(1904) Therapeutic properties of mushrooms in managing adverse
effects in the metabolic syndrome by Kundaković T1, Kolundžić M.(PubMed)
(1905) Dietary supplementation with Agaricus blazei murill extract
prevents diet-induced obesity and insulin resistance in rats by Vincent M1,
Philippe E, Everard A, Kassis N, Rouch C, Denom J, Takeda Y, Uchiyama S, Delzenne NM
(1906) Fermented mushroom milk-supplemented dietary fibre prevents
the onset of obesity and hypertriglyceridaemia in Otsuka Long-Evans Tokushima
fatty rats by Jeon BS1, Park JW, Kim BK, Kim HK, Jung TS, Hahm JR, Kim DR
(1907) The Fruiting Bodies, Submerged Culture Biomass, and Acidic
Polysaccharide Glucuronoxylomannan of Yellow Brain Mushroom Tremella
mesenterica Modulate the Immunity of Peripheral Blood Leukocytes and
Splenocytes in Rats with Impaired Glucose Tolerance by Hsu TH1, Lee CH2, Lin
FY1, Wasser SP3, Lo HC4.(PubMed)
(1908) Characterization of an antihypertensive angiotensin
I-converting enzyme inhibitory peptide from the edible mushroom Hypsizygus
marmoreus by Kang MG1, Kim YH1, Bolormaa Z1, Kim MK2, Seo GS2, Lee JS1.(PubMed)
(1909) Mushroom and dietary selenium intakes in relation to
fasting glucose levels in a free-living Italian adult population: the Moli-sani
Project by Pounis G1, Costanzo S2, Persichillo M2, de Curtis A2, Sieri S3,
Vinceti M4, Zito F1, Di Castelnuovo AF2, Donati MB2, de Gaetano G2, Iacoviello
L5; Moli-sani Project Investigators.(PubMed)
(1910) Dietary supplementation with chitosan derived from
mushrooms changes adipocytokine profile in diet-induced obese mice, a
phenomenon linked to its lipid-lowering action. Neyrinck AM1, Bindels LB, De
Backer F, Pachikian BD, Cani PD, Delzenne NM.(PubMed)
(1911) A polysaccharide from Grifola frondosa relieves insulin
resistance of HepG2 cell by Akt-GSK-3 pathway by Ma X1, Zhou F, Chen Y, Zhang
Y, Hou L, Cao X, Wang C.(PubMed)
(1912) Antidiabetic and antioxidant activities of eight medicinal mushroom
species from china by Wu T1, Xu B2.(PubMed)
(1913-1942)
(1943) Ling Zhi(Complementary and Alternative
Healing University)
(1946) Protective effects of fractional extracts from Panellus
serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice by
Inafuku M1, Nagao K, Nomura S, Shirouchi B, Inoue N, Nagamori N, Nakayama H,
Toda T, Yanagita T.(PubMed)
(1947) Mukitake mushroom (Panellus serotinus) alleviates
nonalcoholic fatty liver disease through the suppression of monocyte
chemoattractant protein 1 production in db/db mice. vtNagao K1, Inoue N,
Inafuku M, Shirouchi B, Morooka T, Nomura S, Nagamori N, Yanagita T.(PubMed)
(1948) Effect of Mukitake mushroom (Panellus serotinus) on the
pathogenesis of lipid abnormalities in obese, diabetic ob/ob mice. Inoue N1,
Inafuku M, Shirouchi B, Nagao K, Yanagita T.(PubMed)
(1949) Impact of ingestion of rice bran and shitake mushroom extract
on lymphocyte function and cytokine production in healthy rats by Giese S1,
Sabell GR, Coussons-Read M.(PubMed)
(1950) Consuming Lentinula edodes (Shiitake) Mushrooms Daily
Improves Human Immunity: A Randomized Dietary Intervention in Healthy Young
Adults by Dai X1, Stanilka JM, Rowe CA, Esteves EA, Nieves C Jr, Spaiser SJ,
Christman MC, Langkamp-Henken B, Percival SS.(PubMed)
(1951) Anti-inflammatory effects of five commercially available
mushroom species determined in lipopolysaccharide and interferon-γ activated
murine macrophage by Gunawardena D1, Bennett L, Shanmugam K, King K, Williams
R, Zabaras D, Head R, Ooi L, Gyengesi E, Münch G.(PubMed)
(1952) A natural formulation (imoviral™) increases macrophage
resistance to LPS-induced oxidative and inflammatory stress in vitr by Menghini
L1, Leporini L1, Pintore G2, Ferrante C1, Recinella L1, Orlando G1, Vacca M1,
Brunetti L1.(PubMed)
(1953) Fumigation with essential oils improves sensory quality and
enhanced antioxidant ability of shiitake mushroom (Lentinus edodes) by Jiang
T1, Luo Z2, Ying T3.(PubMed)
(1954) Expression and characterization of protein Latcripin-3, an
antioxidant and antitumor molecule from Lentinula edodes C91-3 by Ann XH1, Lun
YZ, Zhang W, Liu B, Li XY, Zhong MT, Wang XL, Cao J, Ning AH, Huang M.(PubMed)
(1955) Anti-androgen effects of extracts and compounds from
Ganoderma lucidum by Liu J1, Tamura S, Kurashiki K, Shimizu K, Noda K, Konishi
F, Kumamoto S, Kondo R.(PubMed)
(1956) The use of lentinan for treating gastric cancer by Ina K1,
Kataoka T, Ando T.(PubMed)
(1957) Purification, structural elucidation and antitumor activity
of a novel mannogalactoglucan from the fruiting bodies of Lentinus edodes by
Jeff IB1, Li S, Peng X, Kassim RM, Liu B, Zhou Y.(PubMed)
(1959) Purification and in vitro anti-proliferative effect of
novel neutral polysaccharides from Lentinus edodes. Jeff IB1, Yuan X, Sun L,
Kassim RM, Foday AD, Zhou Y.(PubMed)
(1960) [Antiviral properties of basidiomycetes metabolites].
[Article in Russian] by Avtonomova AV, Krasnopolskaya LM.(PubMed)
(1961) Lentin, a novel and potent antifungal protein from shitake
mushroom with inhibitory effects on activity of human immunodeficiency virus-1
reverse transcriptase and proliferation of leukemia cells by Ngai PH1, Ng TB.(PubMed)
(1962) Lentin, a novel and potent antifungal protein from shitake
mushroom with inhibitory effects on activity of human immunodeficiency virus-1
reverse transcriptase and proliferation of leukemia cells by Ngai PH1, Ng TB.(PubMed)
(1963) Dietary Shiitake Mushroom (Lentinus edodes) Prevents Fat
Deposition and Lowers Triglyceride in Rats Fed a High-Fat Diet by Handayani D1,
Chen J, Meyer BJ, Huang XF.(PubMed)
(1964) Antihyperlipidemic Effect of Dietary Lentinus edodes on
Plasma, Feces and Hepatic Tissues in Hypercholesterolemic Rats by Yoon KN1,
Alam N, Lee JS, Cho HJ, Kim HY, Shim MJ, Lee MW, Lee TS.(PubMed)
(1965) Dietary Shiitake Mushroom (Lentinus edodes) Prevents Fat
Deposition and Lowers Triglyceride in Rats Fed a High-Fat Diet by Handayani D1,
Chen J, Meyer BJ, Huang XF.(PubMed)
(1966) A high-dose Shiitake mushroom increases hepatic
accumulation of triacylglycerol in rats fed a high-fat diet: underlying
mechanism by Handayani D1, Meyer BJ2, Chen J3, Brown SH4, Mitchell TW5, Huang
XF6.(PubMed)
(1967) Lentinus edodes: a macrofungus with pharmacological
activities by Bisen PS1, Baghel RK, Sanodiya BS, Thakur GS, Prasad GB.(PubMed)
(1968) Hypoglycemic effect of a Lentinus edodes exo-polymer
produced from a submerged mycelial cultur by Yang BK1, Kim DH, Jeong SC, Das S,
Choi YS, Shin JS, Lee SC, Song CH.(PubMed)
(1969) Anti-diabetic and anti-hypertensive potential of sprouted
and solid-state bioprocessed soybean by McCue P1, Kwon YI, Shetty K.(PubMed)
(1970) The effects of whole mushrooms during inflammation by Yu
S1, Weaver V, Martin K, Cantorna MT.(PubMed)
(1971) Protective effects of fractional extracts from Panellus
serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice by
Inafuku M1, Nagao K, Nomura S, Shirouchi B, Inoue N, Nagamori N, Nakayama
H, Toda T, Yanagita T.(PubMed)
(1972) Popular #Herbs - #Ginseng, Asian (Panax ginseng) and
Ginseng, North America by Kyle
J. Norton
(1973) Xi yang shen(Complementary and
Alternative Healing University)
(1974) American Ginseng inhibits induced COX-2 and NFKB activation
in breast cancer cells by Peralta EA1, Murphy LL, Minnis J, Louis S, Dunnington
GL.(PubMed)
(1975) Extraction-dependent effects of American ginseng (Panax quinquefolium)
on human breast cancer cell proliferation and estrogen receptor activation by
King ML1, Adler SR, Murphy LL.(PubMed)
(1976) Sensitization of a tumor, but not normal tissue, to the cytotoxic
effect of ionizing radiation using Panax notoginseng extract by Chen FD1, Wu
MC, Wang HE, Hwang JJ, Hong CY, Huang YT, Yen SH, Ou YH.(PubMed)
(1977) Evaluation of the antipsychotic potential of Panax
quinquefolium in ketamine induced experimental psychosis model in mice by
Chatterjee M1, Singh S, Kumari R, Verma AK, Palit G.(PubMed)
(1978) Non-ginsenoside nicotinic activity in ginseng species.
Lewis R1, Wake G, Court G, Court JA, Pickering AT, Kim YC, Perry EK.(PubMed)
(1979) Comparison of the pharmacological effects of Panax ginseng
and Panax quinquefolium by Chen CF1, Chiou WF, Zhang JT.(PubMed)
(1980) Cytoprotective effect of American ginseng in a rat ethanol
gastric ulcer model by Huang CC1, Chen YM1, Wang DC1, Chiu CC1, Lin WT1, Huang
CY1, Hsu MC2.(PubMed)
(1981) Evaluation of antibacterial and anti-inflammatory
activities of less polar ginsenosides produced from polar ginsenosides by
heat-transformation by Wang L1, Yang X, Yu X, Yao Y, Ren G.(PubMed)
(1982) Possible differential induction of phase 2 enzyme and
antioxidant pathways by american ginseng, Panax quinquefolius by Lee LS1, Wise
SD, Chan C, Parsons TL, Flexner C, Lietman PS.(PubMed)
(1983) Neoplasm prevention and immuno-enhancement mediated by
daily consumption of a proprietary extract from North American ginseng by elderly
mice of a cancer-prone strain by Durairaj P1, Miller SC.(PubMed)
(1984) Dietary supplementation with an extract of North American
ginseng in adult and juvenile mice increases natural killer cells by Miller
SC1, Ti L, Shan J.(PubMed)
(1985) Ginseng, sex behavior, and nitric oxide by Murphy LL1, Lee
TJ.(PubMed)
(1986) Ginsenosides-induced nitric oxide-mediated relaxation of
the rabbit corpus cavernosum by Chen X1, Lee TJ.(PubMed)
(1987) Compound CVT-E002 attenuates allergen-induced airway inflammation
and airway hyperresponsiveness, in vivo by Ebeling C1, Wu Y, Skappak C, Gordon
JR, Ilarraza R, Adamko DJ.(PubMed)
(1988) Anti-fatigue effects of proteins isolated from Panax
quinquefolium by Qi B1, Liu L1, Zhang H1, Zhou GX1, Wang S1, Duan XZ1, Bai XY1,
Wang SM1, Zhao DQ2.(PubMed)
(1989) American ginseng does not improve fatigue in multiple
sclerosis: a single center randomized double-blind placebo-controlled crossover
pilot study by Kim E1, Cameron M, Lovera J, Schaben L, Bourdette D, Whitham R.(PubMed)
(1991) The role of spinal adrenergic receptors on the
antinociception of ginsenosides in a rat postoperative pain model by Kim IJ1,
Park CH, Lee SH, Yoon MH.(PubMed)
(1992) Additive interaction of intrathecal ginsenosides and
neostigmine in the rat formalin test by Park CH1, Kim PN, Lee SH, Yoon MH.(PubMed)
(1993) Targeting metabolic syndrome: candidate natural agents. Xia
X1, Weng J.(PubMed)
(1994) Traditional chinese medicine in treatment of metabolic
syndrome by Yin J1, Zhang H, Ye J.(PubMed)
(1995) Vinegar-processed ginseng radix improves metabolic syndrome
induced by a high fat diet in ICR mice by Yun SN1, Ko SK, Lee KH, Chung SH.(PubMed)
(1996) Konjac-Mannan and American ginsing: emerging alternative
therapies for type 2 diabetes mellitus by Vuksan V1, Sievenpiper JL, Xu Z, Wong
EY, Jenkins AL, Beljan-Zdravkovic U, Leiter LA, Josse RG, Stavro MP.(PubMed)
(1997) American ginseng acutely regulates contractile function of
rat heart by Jiang M1, Murias JM2, Chrones T3, Sims SM3, Lui E4, Noble EG1.(PubMed)
(1998) Shenyuan, an extract of American Ginseng and Corydalis
Tuber formula, attenuates cardiomyocyte apoptosis via inhibition of endoplasmic
reticulum stress and oxidative stress in a porcine model of acute myocardial
infarction by Zhu XY1, Zhang ZL, Li P, Liang WY, Feng XR, Liu ML.(PubMed)
(1999) American Ginseng Extract (Panax quinquefolius L.) Is Safe
in Long-Term Use in Type 2 Diabetic Patients. Mucalo I1, Jovanovski E2, Vuksan
V3, Božikov V4, Romić Z5, Rahelić D4.(PubMed)
(2000) Effect of American ginseng (Panax quinquefolius L.) on
glycemic control in type 2 diabetes by Mucalo I1, Rahelić D, Jovanovski E,
Bozikov V, Romić Z, Vuksan V.(PubMed)
(2001) American ginseng (Panax quinquefolius L) reduces
postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes
mellitus by Vuksan V1, Sievenpiper JL, Koo VY, Francis T, Beljan-Zdravkovic U,
Xu Z, Vidgen E.(PubMed)
(2002) Panax quinquefolium saponins protects low density
lipoproteins from oxidation by Li J1, Huang M, Teoh H, Man RY.(PubMed)
(2003) Preventive effects of North American Ginseng (Panax quinquefolius)
on Diabetic Retinopathy and Cardiomyopathy, vy Subhrojit Sen,1,3 Shali Chen,1
Yuexiu Wu,1 Biao Feng,1 Edmund K Lui2,3 and Subrata Chakrabarti1,3*(PHYTOTHERAPY
RESEARCH)
(2004) Ganoderma lucidum (Reishi mushroom) for cancer treatment by
Jin X1, Ruiz Beguerie J, Sze DM, Chan GC.(PubMed)
(2005) Ganoderma lucidum inhibits proliferation of human ovarian
cancer cells by suppressing VEGF expression and up-regulating the expression of
connexin 43 by Dai S1, Liu J, Sun X, Wang N.(PubMed)
(2006) Suppression of proliferation and oxidative stress by
extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3 by Hsieh
TC1, Wu JM.(PubMed)
(2007) Anti-tumor effects of Ganoderma lucidum (reishi) in
inflammatory breast cancer in in vivo and in vitro models by Suarez-Arroyo IJ1,
Rosario-Acevedo R, Aguilar-Perez A, Clemente PL, Cubano LA, Serrano J,
Schneider RJ, Martínez-Montemayor MM.(PubMed)
(2008) Ganoderma lucidum (Reishi) inhibits cancer cell growth and
expression of key molecules in inflammatory breast cancer by
Martínez-Montemayor MM1, Acevedo RR, Otero-Franqui E, Cubano LA, Dharmawardhane
SF.(PubMed)
(2009) Neurometabolic Effect of Altaian Fungus Ganoderma lucidum
(Reishi Mushroom) in Rats Under Moderate Alcohol Consumption by Shevelev OB1,
Akulov AE1, Dotsenko AS2, Kontsevaya GV1, Zolotykh MA2, Gerlinskaya LA1, Veprev
SG1, Goryachkovskaya TN1, Zhukova NA3, Kolchanov NA1,3, Pel'tek SE1, Moshkin
MP1,2,4(PubMed)
(2010) Antidiabetic, antihyperlipidemic and antioxidant activities
of a novel proteoglycan from ganoderma lucidum fruiting bodies on db/db mice
and the possible mechanism by Pan D1, Zhang D, Wu J, Chen C, Xu Z, Yang H, Zhou
P.(PubMed)
(2011) Structural characterization and antioxidative activity of
low-molecular-weights beta-1,3-glucan from the residue of extracted Ganoderma
lucidum fruiting bodies by Kao PF1, Wang SH, Hung WT, Liao YH, Lin CM, Yang
WB.(PubMed)
(2012) Neuroprotective effect of preadministration with Ganoderma
lucidum spore on rat hippocampus by Zhou Y1, Qu ZQ, Zeng YS, Lin YK, Li Y,
Chung P, Wong R, Hägg U.
(2013) Determination of the antioxidant activity and polyphenol
contents of wild Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum
(W.Curt. Fr.) P. Karst. (higher Basidiomycetes) from central Himalayan hills of
India
(2014) Immuno-modulatory activity of Ganoderma lucidum-derived
polysacharide on human monocytoid dendritic cells pulsed with Der p 1 allergen
by Jan RH1, Lin TY, Hsu YC, Lee SS, Lo SY, Chang M, Chen LK, Lin YL.(PubMed)
(2015) Optimization extraction of Ganoderma lucidum
polysaccharides and its immunity and antioxidant activities. Pan K1, Jiang Q,
Liu G, Miao X, Zhong D.(PubMed)
(2016) In vitro and in vivo protective effects of proteoglycan
isolated from mycelia of Ganoderma lucidum on carbon tetrachloride-induced
liver injury by Yang XJ1, Liu J, Ye LB, Yang F, Ye L, Gao JR, Wu ZH.(PubMed)
(2017) Hepatoprotective effects of mushrooms by Soares AA1, de
Sá-Nakanishi AB, Bracht A, da Costa SM, Koehnlein EA, de Souza CG, Peralta RM.(PubMed)
(2018) Hepatoprotective effects of aqueous extract from Lingzhi or
Reishi medicinal mushroom Ganoderma lucidum (higher basidiomycetes) on
α-amanitin-induced liver injury in mice by Wu X1, Zeng J, Hu J, Liao Q, Zhou R,
Zhang P, Chen Z.(PübMed)
(2019) Antagonizing beta-amyloid peptide neurotoxicity of the
anti-aging fungus Ganoderma lucidum by Lai CS1, Yu MS, Yuen WH, So KF, Zee SY,
Chang RC.(PubMed)
(2020) Neuroprotective effects of anti-aging oriental medicine
Lycium barbarum against beta-amyloid peptide neurotoxicit by Yu MS1, Leung SK
(2021) Ling zhi(Complementary and Alternative
Healing University)
(2022) Pharmacophore-based discovery of FXR-agonists. Part II:
identification of bioactive triterpenes from Ganoderma lucidum by Grienke U1,
Mihály-Bison J, Schuster D, Afonyushkin T, Binder M, Guan SH, Cheng CR, Wolber
G, Stuppner H, Guo DA, Bochkov VN, Rollinger JM.(PubMed)
(2023) Effect of Ganoderma lucidum extract on adipocyte
differentiation and adiponectin gene expression in the murine pre-adipocyte
cell line, 3T3-L1. by Shimojo Y1, Kosaka K, Shirasawa T.(PubMed)
(2024) Ganoderma lucidum mushroom for the treatment of
cardiovascular risk factors by Klupp NL1, Chang D, Hawke F, Kiat H, Cao H,
Grant SJ, Bensoussan A.(PubMed)
(2025) Antihyperglycemic effect of ganoderma lucidum
polysaccharides on streptozotocin-induced diabetic mice by Li F1, Zhang Y,
Zhong Z.(PubMed)
(2026) Isolation and structure determination of a cholesterol
esterase inhibitor from Ganoderma lucidum by Kim SD1.(PubMed)
(2027) Effect of 26-oxygenosterols from Ganoderma lucidum and
their activity as cholesterol synthesis inhibitors by Hajjaj H1, Macé C,
Roberts M, Niederberger P, Fay LB.(PubMed)
(2028) Hypoglycemic effects of Ganoderma lucidum polysaccharides
in type 2 diabetic mice by Xiao C1, Wu QP, Cai W, Tan JB, Yang XB, Zhang JM.(PubMed)
(2029) Effect of astragaloside IV on hepatic glucose-regulating
enzymes in diabetic mice induced by a high-fat diet and streptozotocin by Lv
L1, Wu SY, Wang GF, Zhang JJ, Pang JX, Liu ZQ, Xu W, Wu SG, Rao JJ.(PubMed)
(2030) Effect of geniposide, a hypoglycemic glucoside, on hepatic
regulating enzymes in diabetic mice induced by a high-fat diet and
streptozotocin by Wu SY1, Wang GF, Liu ZQ, Rao JJ, Lü L, Xu W, Wu SG, Zhang
JJ.(PubMed)
(2031) Treatment of glomerular endothelial dysfunction in
steroid-resistant nephrosis with Ganoderma lucidum, vitamins C, E and
vasodilators by Futrakul N1, Boonyen M, Patumraj S, Siriviriyakul P,
Tosukhowong P, Futrakul P.(PubMed)
(2032) Wound healing activity of an aqueous extract of the Lingzhi
or Reishi medicinal mushroom Ganoderma lucidum (higher Basidiomycetes) by Gupta
A1, Kirar V1, Keshri GK1, Gola S1, Yadav A1, Negi PS2, Misra K3.(PubMed)
(2033) Anti-angiotensin converting enzyme (ACE) proteins from
mycelia of Ganoderma lucidum (Curtis) by P. Karst. Mohamad Ansor N1, Abdullah
N, Aminudin N.(PubMed)
(2034) Development of Lingzhi or Reishi medicinal mushroom,
Ganoderma lucidum (Higher Basidiomycetes) polysaccharides injection formulation
by Jiang Y1, He A2, Liu Y3, Xie B1, Li Y4, Deng Y5, Liu X5, Liu Q6.(PubMed)
(2035) Changes in weight gain, faecal oocyst count and packed cell
volume of Eimeria tenella-infected broilers treated with a wild mushroom
(Ganoderma lucidum) aqueous extract by Ogbe AO1, Atawodi SE, Abdu PA, Sannusi
A, Itodo AE.(PubMed)
(2036) [Role of phytotherapy in the prevention and treatment of
obesity]. [Article in Hungarian] by Balázs A1.(PubMed)
(2037) Berberine inhibits LPS-induced TF procoagulant activity and
expression through NF-κB/p65, Akt and MAPK pathway in THP-1 cells by Gao MY1,
Chen L1, Yang L1, Yu X1, Kou JP2, Yu BY3.(PubMed)
(2038) Berberine, a natural lipid-lowering drug, exerts
prothrombotic effects on vascular cells by Holy EW1, Akhmedov A, Lüscher TF,
Tanner FC.(PubMed)
(2039) Cardiovascular actions of berberine by Lau CW1, Yao XQ,
Chen ZY, Ko WH, Huang Y.(PubMed)
(2040) Berberine elicits anti-arrhythmic effects via IK1/Kir2.1 in
the rat type 2 diabetic myocardial infarction model by Wang LH1, Yu CH, Fu Y,
Li Q, Sun YQ.(PubMed)
(2041)Application of berberine on treating type 2 diabetes
mellitus by Pang B1, Zhao LH2, Zhou Q3, Zhao TY1, Wang H1, Gu CJ1, Tong XL1.(PubMed)
(2042) Berberine as a promising anti-diabetic nephropathy drug: An
analysis of its effects and mechanisms by Ni WJ1, Ding HH2, Tang LQ3.(PubMed)
(2043) Huang lian(Complementary and
Alternative Healing University)
(2044) Inhibitory effect of Coptidis Rhizoma and berberine on the
proliferation of human esophageal cancer cell lines by Iizuka N1, Miyamoto K,
Okita K, Tangoku A, Hayashi H, Yosino S, Abe T, Morioka T, Hazama S, Oka M.(PubMed)
(2045) Suppression of human breast cancer cell metastasis by
coptisine in vitro by Li J1, Qiu DM, Chen SH, Cao SP, Xia XL.(PubMed)
(2046) Berberine hydrochloride impact on physiological processes
and modulation of twist levels in nasopharyngeal carcinoma CNE-1 cells by Li
CH1, Wu DF, Ding H, Zhao Y, Zhou KY
(2047) Analysis of the antioxidative function of the
radioprotective Japanese traditional (Kampo) medicine, hangeshashinto, in an
aqueous phase by Matsumoto C1, Sekine-Suzuki E2, Nyui M3, Ueno M3, Nakanishi
I3, Omiya Y4, Fukutake M1, Kase Y4, Matsumoto KI5.(PubMed)
(2048) Characterization, antibacterial, antioxidant, and cytotoxic
activities of ZnO nanoparticles using Coptidis Rhizoma by Nagajyothi PC1,
Sreekanth TV2, Tettey CO1, Jun YI1, Mook SH3.(PubMed)
(2049) Coptisine attenuates obesity-related inflammation through
LPS/TLR-4-mediated signaling pathway in Syrian golden hamsters by Zou ZY1, Hu
YR1, Ma H1, Wang YZ1, He K1, Xia S1, Wu H2, Xue DF2, Li XG3, Ye XL4.(PubMed)
(2050) [Progress of berberine for treatment of type 2 diabetes].
[Article in Chinese] by Deng XW, Xie N.(PubMed)
(2051) Berberine and Coptidis rhizoma as novel antineoplastic
agents: a review of traditional use and biomedical investigations by Tang J1,
Feng Y, Tsao S, Wang N, Curtain R, Wang Y.(PubMed)
(2052) Safety evaluation of main alkaloids from Rhizoma Coptidis
by Yi J1, Ye X, Wang D, He K, Yang Y, Liu X, Li X.(PubMed)
(2053) Effects of San-Huang-Xie-Xin-tang, a traditional Chinese
prescription for clearing away heat and toxin, on the pacemaker activities of
interstitial cells of Cajal from the murine small intestine by Kim BJ1, Kim H2,
Lee GS3, So I4, Kim SJ5.(PubMed)
(2054) Study of the anti-MRSA activity of Rhizoma coptidis by
chemical fingerprinting and broth microdilution methods by Luo JY1, Yan D2,
Yang MH3.(PubMed)
(2055) Analgesic effect of Coptis chinensis rhizomes (Coptidis
Rhizoma) extract on rat model of irritable bowel syndrome by Tjong Y1, Ip S,
Lao L, Fong HH, Sung JJ, Berman B, Che C.(PubMed)
(2056) Integrated pharmacokinetics of five protoberberine-type
alkaloids in normal and insomnic rats after single and multiple oral
administration of Jiao-Tai-Wan by He W1, Liu G1, Cai H1, Sun X1, Hou W1, Zhang
P2, Xie Z3, Liao Q4.(PubMed)
(2057) Anti-atherosclerotic action of Ger-Gen-Chyn-Lian-Tang and
AMPK-dependent lipid lowering effect in hepatocytes. Ho FM1, Liao YH, Yang AJ,
Lee Chao PD, Hou YC, Huang CT, Lin SR, Lee KR, Huang KC, Lin WW.(PubMed)
(2058) Coptisine exert cardioprotective effect through
anti-oxidative and inhibition of RhoA/Rho kinase pathway on
isoproterenol-induced myocardial infarction in rats by Gong LL1, Fang LH, Wang
SB, Sun JL, Qin HL, Li XX, Wang SB, Du GH.(PubMed)
(2059) Effect of Coptidis Rhizoma extracts in a water-based
solution on insulin resistance in 3T3-L1 adipocytes by Yuan Y1, Wang X, Lu X,
Marunaka Y, Wang X.(PubMed)
(2060) Letrozole, berberine, or their combination for anovulatory
infertility in women with polycystic ovary syndrome: study design of a
double-blind randomised controlled trial by Li Y1, Kuang H, Shen W, Ma H, Zhang
Y, Stener-Victorin E, Hung E, Ng Y, Liu J, Kuang H, Hou L, Wu X.(PubMed)
(2061) Gut microbes and Effects and action mechanisms of berberine
and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J
mice by Xie W1, Gu D, Li J, Cui K, Zhang Y.(PubMed)
(2062) Ameliorative effect of berberine on renal damage in rats
with diabetes induced by high-fat diet and streptozotocin by Wu D1, Wen W, Qi
CL, Zhao RX, Lü JH, Zhong CY, Chen YY.(PubMed)
(2063) Jiao tai wan attenuates hepatic lipid accumulation in type
2 diabetes mellitus by Huang Z1, Xu X, Lu F, Wang N, Chen G, Zhao Y, Zou X,
Wang K, Dong H, Xu L.(PubMed)
(2064) Traditional chinese medicine in treatment of metabolic
syndrome by Yin J1, Zhang H, Ye J. (PubMed)
(2065) Simultaneous determination of ten alkaloids of crude and
wine-processed Rhizoma Coptidis aqueous extracts in rat plasma by
UHPLC-ESI-MS/MS and its application to a comparative pharmacokinetic study by
Qian XC1, Zhang L2, Tao Y3, Huang P1, Li JS4, Chai C3, Li W5, Di LQ1, Cai BC3.(PubMed)
(2066) Effects of San-Huang-Xie-Xin-Tang on U46619-induced
increase in pulmonary arterial blood pressure by Tsai HH1, Chen IJ, Lo YC.(PubMed)
(2067) Coptis chinensis alkaloids exert anti-adipogenic activity
on 3T3-L1 adipocytes by downregulating C/EBP-α and PPAR-γ by Choi JS1, Kim JH2,
Ali MY1, Min BS3, Kim GD4, Jung HA5.(PubMed)
(2068) [Pharmacodyamic material basis of rhizoma coptidis on
insulin resistance]. [Article in Chinese] by Li J1, Meng X, Fan X, Lai X, Zhang
Y, Zeng Y.(PubMed)
(2069) Inhibition of preadipocyte differentiation and lipid
accumulation by Orengedokuto treatment of 3T3-L1 cultures. Ikarashi N1, Tajima
M, Suzuki K, Toda T, Ito K, Ochiai W, Sugiyama K.(PubMed)
(2070) Potential ex vivo immunomodulatory effects of
San-Huang-Xie-Xin-Tang and its component herbs on mice and humans by Li CY1,
Hou YC, Lee Chao PD, Shia CS, Hsu IC, Fang SH.(PubMed)
(2071) Lipopolysaccharide increased the acute toxicity of the
Rhizoma coptidis extract in mice by increasing the systemic exposure to Rhizoma
coptidis alkaloids by Ma BL1, Ma YM, Gao CL, Wu JS, Qiu FR, Wang CH, Wang XH.(PubMed)
(2073) [Research on building method of spleen kidney Yang
deficiency diarrhea rats model]. [Article in Chinese] by Pan X, Hu CJ, Geng YY,
Zhao L, Wu WH, Wu XQ, Zhong ZD.(PubMed)
(2074) Treatment of an elderly patient with acute abdominal pain
with traditional Korean medicine by Son CG1.(PubMed)
(2075) Shenzhu Tiaopi granule combined with lifestyle intervention
therapy for impaired glucose tolerance: a randomized controlled trial by Fang
Z1, Zhao J2, Shi G3, Shu Y3, Ni Y3, Wang H3, Ding L3, Lu R3, Li J3, Zhu X3,
Cheng S4, Zhang X3, Liu Y5, Wang J6, Luo Y3, Fan Q3, Guo C3, Jiang T3, Wu Q3,
Fan L3, Ling H3, Cui L3, Luo Y3, Yang H3, Anderson RM7.(PubMed)
(2075) Direct moxibustion to treat spleen qi and yang deficiency
fatigue: a pilot study by Thorne TL1, Hanes DA2, Wild H3, Colbert A4.(PubMed)
(2076) [Clinical observation on fuzhong (supporting the
middle-jiao) manipulation of tuina for infantile anorexia]. [Article in
Chinese] by Wang YY, Liu XY.(PubMed)
(2077) [Effect of umbilicus moxibustion therapy on physical
conditions of yang-deficiency volunteers]. [Article in Chinese] by Zhang YY1.(PubMed)
(2078) Analysis of the restorative effect of Bu-zhong-yi-qi-tang
in the spleen-qi deficiency rat model using (1)H-NMR-based metabonomics by
Zheng XF1, Tian JS2, Liu P3, Xing J1, Qin XM1.(PubMed)
(2079) [1H NMR based metabolomics study of bu-zhong-yi-qi-tang in
the spleen-qi deficiency rat model]. [Article in Chinese] by Chen L, Xiang H,
Xing J, Tian JS, Qin XM, Du GH.(PubMed)
(2080) Bufei Jianpi granules improve skeletal muscle and
mitochondrial dysfunction in rats with chronic obstructive pulmonary disease by
Dong Y1,2, Li Y3,4,5, Sun Y6, Mao J7, Yao F8, Tian Y9, Wang L10, Li L11, Li
S12,13,14, Li J15,16,17(PubMed)
(2081) [Clinical observation on obesity and hyperlipidemia of
liver qi stagnation and spleen deficiency pattern in female patients treated
with combined therapy of acupuncture and tapping method]. [Article in Chinese]
by Wu B, Liu ZC, Xu B.(PubMed)
(2082) Phytopharmacological Properties of Coriander Sativum as a
Potential Medicinal Tree: An Overview by Pathak Nimish L, Kasture Sanjay B,
Bhatt Nayna M and Rathod Jaimik D.(The Journal of
Applied pharmaceutical Science)
(2083) Coriander leaf extract exerts antioxidant activity and
protects against UVB-induced photoaging of skin by regulation of procollagen
type I and MMP-1 expression by Hwang E1, Lee DG, Park SH, Oh MS, Kim SY.(PubMed)
(2084) Coriander alleviates 2,4-dinitrochlorobenzene-induced
contact dermatitis-like skin lesions in mice by Park G1, Kim HG, Lim S, Lee W,
Sim Y, Oh MS.(PubMed)
(2085) [Study of an antioxidant dietary supplement
"Karinat" in patients with benign breast disease]. [Article in
Russian] by Bespalov VG, Barash NIu, Ivanova OA, Krzhivitskiĭ PI, Semiglazov
VF, Aleksandrov VA, Sobenin NA, Orekhov AN.(PubMed)
(2086) Carrot juice junkies and big bangs by Martin-Du Pan R, Herrmann
W.(PubMed)
(2087) Effects of hydroalcoholic extract of Coriandrum sativum on
oxidative damage in pentylenetetrazole-induced seizures in rats by Karami R1,
Hosseini M2, Mohammadpour T3, Ghorbani A4, Sadeghnia HR4, Rakhshandeh H4,
Vafaee F3, Esmaeilizadeh M5.(PubMed)
(2088) In vitro free radical scavenging and DNA damage protective
property of Coriandrum sativum L. leaves extract by Harsha SN1, Anilakumar
KR1.(PubMed)
(2089) Antioxidant and hepatoprotective potential of essential
oils of coriander (Coriandrum sativum L.) and caraway (Carum carvi L.)
(Apiaceae) by Samojlik I1, Lakić N, Mimica-Dukić N, Daković-Svajcer K, Bozin
B.(PubMed)
(2090) Effect of coriander on thioacetamide-induced hepatotoxicity
in rats by Moustafa AH1, Ali EM2, Moselhey SS1, Tousson E3, El-Said KS2.(PubMed)
(2091) Cognitive-enhancing and antioxidant activities of inhaled
coriander volatile oil in amyloid β(1-42) rat model of Alzheimer's disease by
Cioanca O1, Hritcu L, Mihasan M, Hancianu M.(PubMed)
(2092) Inhalation of coriander volatile oil increased
anxiolytic-antidepressant-like behaviors and decreased oxidative status in
beta-amyloid (1-42) rat model of Alzheimer's disease by Cioanca O1, Hritcu L2,
Mihasan M3, Trifan A1, Hancianu M1.(PubMed)
(2093) Reversal of memory deficits by Coriandrum sativum leaves in
mice. Mani V1, Parle M, Ramasamy K, Abdul Majeed AB.(PubMed)
(2094) The cholesterol lowering property of coriander seeds
(Coriandrum sativum): mechanism of action by Dhanapakiam P1, Joseph JM,
Ramaswamy VK, Moorthi M, Kumar AS.(PubMed)
(2095) Petroselinic acid from dietary triacylglycerols reduces the
concentration of arachidonic acid in tissue lipids of rats by Weber N1, Richter
KD, Schulte E, Mukherjee KD.(PubMed)
(2096) Coriander fruit exhibits gut modulatory, blood pressure
lowering and diuretic activities by Jabeen Q1, Bashir S, Lyoussi B, Gilani AH.(PubMed)
(2097) The efficacy of an herbal medicine, Carmint, on the relief
of abdominal pain and bloating in patients with irritable bowel syndrome: a
pilot study by Vejdani R1, Shalmani HR, Mir-Fattahi M, Sajed-Nia F, Abdollahi
M, Zali MR, Mohammad Alizadeh AH, Bahari A, Amin G.(PubMed)
(2098) Anti-inflammatory and cytoprotective effects of selected
Pakistani medicinal plants in Helicobacter pylori-infected gastric epithelial
cells by Zaidi SF1, Muhammad JS, Shahryar S, Usmanghani K, Gilani AH, Jafri W,
Sugiyama T.(PubMed)
(2099) Coriander (Coriandrum sativum L.) and its bioactive
constituents by Laribi B1, Kouki K2, M'Hamdi M3, Bettaieb T2.(PubMed)
(2100) Enhancement of folate content and its stability using food
grade elicitors in coriander (Coriandrum sativum L.) by Puthusseri B1, Divya P,
Lokesh V, Neelwarne B.(PubMed)
(2101) Effects of different levels of coriander (Coriandrum
sativum) seed powder and extract on serum biochemical parameters, microbiota,
and immunity in broiler chicks by Hosseinzadeh H1, Alaw Qotbi AA1, Seidavi A1,
Norris D2, Brown D2.(PubMed)
(2102) Hypoglycemic and hypolipidemic effects of Coriandrum
sativum L. in Meriones shawi rats by Aissaoui A1, Zizi S, Israili ZH, Lyoussi
B.(PubMed)
(2103) Postprandial glycaemia and inhibition of α-glucosidase
activity by aqueous extract from Coriandrum sativum by Brindis F1,
González-Andrade M, González-Trujano ME, Estrada-Soto S, Villalobos-Molina R.(PubMed)
(2104) Antioxidant, antihyperglycemic, and antihyperlipidemic
effects of Coriandrum sativum leaf and stem in alloxan-induced diabetic rats by
Sreelatha S1, Inbavalli R.(PubMed)
(2105) Hypolipidemic effect of Coriandrum sativum L. in
triton-induced hyperlipidemic rats by Lal AA1, Kumar T, Murthy PB, Pillai KS.(PubMed)
(2106) Green synthesis of multifunctional carbon dots from
coriander leaves and their potential application as antioxidants, sensors and
bioimaging agents by Sachdev A1, Gopinath P.(PubMed)
(2107) Evaluation of coriander spice as a functional food by using
in vitro bioassays by Zhang CR1, Dissanayake AA1, Kevseroğlu K2, Nair MG3.(PubMed)
(2108) Anti-granuloma activity of Coriandrum sativum in
experimental models by Nair V1, Singh S, Gupta YK.(PubMed)
(2109) [Contributions to the chemical study of the essential oil
isolated from coriander fruits (Sandra cultivar)]. [Article in Romanian] by
Trifan A1, Aprotosoaie AC, Spac A, Hăncianu M, Miron A, Stănescu U.(PubMed)
(2110) Antioxidant potential of Coriandrum sativum L. seed extract
by Deepa B1, Anuradha CV.(PubMed)
(2111) Optimising aroma quality in curry sauce products using in
vivo aroma release measurements by Hatakeyama J1, Davidson JM2, Kant A2,
Koizumi T3, Hayakawa F4, Taylor AJ2.(PubMed)
(2112) Recent Advances in the Methodology and Application for the
Metabolism of Phytochemical Compounds-An Update Covering the Period of
2009-2014 by Cao W, Yi L, Cao J1, Hu SS, Li P.(PubMed)
(2113) Total coumarins from Urtica dentata Hand prevent murine
autoimmune diabetes via suppression of the TLR4-signaling pathways by Wang J1,
Lu J, Lan Y, Zhou H, Li W, Xiang M.(PubMed)
(2114) Aculeatin, a coumarin derived from Toddalia asiatica (L.)
Lam., enhances differentiation and lipolysis of 3T3-L1 adipocytes by Watanabe
A1, Kato T2, Ito Y2, Yoshida I2, Harada T2, Mishima T2, Fujita K2, Watai M2,
Nakagawa K3, Miyazawa T3.(PubMed)
(2115) Cinnamic acid exerts anti-diabetic activity by improving
glucose tolerance in vivo and by stimulating insulin secretion in vitro by
Hafizur RM1, Hameed A2, Shukrana M3, Raza SA2, Chishti S2, Kabir N4, Siddiqui
RA2.(PubMed)
(2116) Cinnamon: A Multifaceted Medicinal Plant by Pasupuleti
Visweswara Rao 1 , 2 ,* and Siew Hua Gan 2(PubMed)dyslipidaemia
and oxidative stress in streptozotocin-nicotinamide diabetic rats by Madkor
HR1, Mansour SW, Ramadan G.(PubMed)(2117) Jiang
huang(Complementary and
Alternative Healing University)
(2118) Effects of ingested turmeric oleoresin on glucose and lipid
metabolisms in obese diabetic mice: a DNA microarray study by Honda S1, Aoki F,
Tanaka H, Kishida H, Nishiyama T, Okada S, Matsumoto I, Abe K, Mae T.(PubMed)
(2119) Herbal composition Gambigyeongsinhwan (4) from curcuma
longa, Alnus japonica, and massa Medicata Fermentata inhibits lipid
accumulation in 3T3-L1 cells and regulates obesity in Otsuka long-Evans
Tokushima fatty rats by Sung Roh J1, Lee H2, Woo S2, Yoon M2, Kim J2, Dong Park
S3, Shik Shin S4, Yoon M5.(PubMed)
(2120) Efficacy of turmeric (curcumin) in pain and postoperative
fatigue after laparoscopic cholecystectomy: a double-blind, randomized
placebo-controlled study by Agarwal KA1, Tripathi CD, Agarwal BB, Saluja S.(PubMed)
(2121) Intrathecal curcumin attenuates pain hypersensitivity and
decreases spinal neuroinflammation in rat model of monoarthritis by Chen JJ1,
Dai L2, Zhao LX3, Zhu X4, Cao S4, Gao YJ3.(PubMed)
(2122) Turmeric extracts containing curcuminoids prevent
experimental rheumatoid arthritis by Funk JL1, Oyarzo JN, Frye JB, Chen G,
Lantz RC, Jolad SD, Sólyom AM, Timmermann BN.(PubMed)
(2123) Efficacy and mechanism of action of turmeric supplements in
the treatment of experimental arthritis by Funk JL1, Frye JB, Oyarzo JN,
Kuscuoglu N, Wilson J, McCaffrey G, Stafford G, Chen G, Lantz RC, Jolad SD,
Sólyom AM, Kiela PR, Timmermann BN.(PubMed)
(2124) Comparative evaluation of single application of 2% whole
turmeric gel versus 1% chlorhexidine gel in chronic periodontitis patients: A
pilot study by Jaswal R1, Dhawan S1, Grover V1, Malhotra R1.(PubMed)
(2125) Evaluation of local drug-delivery system containing 2%
whole turmeric gel used as an adjunct to scaling and root planing in chronic
periodontitis: A clinical and microbiological study by Behal R1, Mali AM, Gilda
SS, Paradkar AR.(PubMed)
(2126) Chemopreventive effect of turmeric against stomach and skin
tumors induced by chemical carcinogens in Swiss mice by Azuine MA1, Bhide SV.(PubMed)
(2127) Adjuvant chemoprevention of experimental cancer: catechin
and dietary turmeric in forestomach and oral cancer models by Azuine MA1, Bhide
SV.(PubMed)
(2128) Combination Efficacy of Astragalus membranaceus and Curcuma
wenyujin at Different Stages of Tumor Progression in an Imageable Orthotopic
Nude Mouse Model of Metastatic Human Ovarian Cancer Expressing Red Fluorescent
Protein by Yin G1, Tang D2, Dai J1, Liu M1, Wu M1, Sun YU3, Yang Z4, Hoffman
RM5, Li L1, Zhang S1, Guo X1.(PubMed)
(2129) Curcumin inhibits herpes simplex virus immediate-early gene
expression by a mechanism independent of p300/CBP histone acetyltransferase
activity by Kutluay SB1, Doroghazi J, Roemer ME, Triezenberg SJ.(PubMed)
(2130) Downregulation of cellular c-Jun N-terminal protein kinase
and NF-κB activation by berberine may result in inhibition of herpes simplex
virus replication by Song S1, Qiu M1, Chu Y1, Chen D1, Wang X1, Su A1, Wu Z2.(PubMed)
(2131) Are curcuminoids effective C-reactive protein-lowering
agents in clinical practice? Evidence from a meta-analysis by Sahebkar A1.(PubMed)
(2132) Therapeutic roles of curcumin: lessons learned from
clinical trials by Gupta SC1, Patchva S, Aggarwal BB.(PubMed)
(2133) Spicing up endogenous neural stem cells: aromatic-turmerone
offers new possibilities for tackling neurodegeneration by Poser SW,
Androutsellis-Theotokis A.(PubMed)
(2134) Aromatic-turmerone induces neural stem cell proliferation
in vitro and in vivo by Hucklenbroich J1,2, Klein R3,4, Neumaier B5, Graf R6,
Fink GR7,8, Schroeter M9,10,11, Rueger MA12,13,14.(PubMed)
(2135) Turmeric and green tea: a recipe for the treatment of
B-chronic lymphocytic leukemia by Angelo LS1, Kurzrock R.(PubMed)
(2136) Curcumin inhibits prosurvival pathways in chronic
lymphocytic leukemia B cells and may overcome their stromal protection in
combination with EGCG by Ghosh AK1, Kay NE, Secreto CR, Shanafelt TD.(PubMed)
(2137) Clinical efficacy of the co-administration of Turmeric and
Black seeds (Kalongi) in metabolic syndrome - a double blind randomized
controlled trial - TAK-MetS trial by Amin F1, Islam N2, Anila N3, Gilani AH4.(PubMed)
(2138) Effect of a Natural Supplement Containing Curcuma Longa,
Guggul, and Chlorogenic Acid in Patients With Metabolic Syndrome by Patti AM1,
Al-Rasadi K2, Katsiki N3, Banerjee Y4, Nikolic D1, Vanella L5, Giglio RV1,
Giannone VA1, Montalto G1, Rizzo M6.(PubMed)
(2139) Hypoglycemic, hypolipidemic and antioxidant properties of
combination ofCurcumin fromCurcuma longa, Linn, and partially purified product
fromAbroma augusta, Linn. in streptozotocin induced diabetes by Ali Hussain
HE1.(PubMed)
(2140) [Screening of pancreatic lipase and alpha-glucosidase
inhibitors from Chinese dietary herbs]. [Article in Chinese] by Sun X1, Zhang
K, Ji X, Wang Y, Jeffrey Z, Tong Y, Gao H, Zhang J, Wang Z.(PubMed)
(2141) Effect of curcumin on hepatic heme oxygenase 1 expression
in high fat diet fed rats: is there a triangular relationship? by Öner-İyidoğan
Y1, Tanrıkulu-Küçük S, Seyithanoğlu M, Koçak H, Doğru-Abbasoğlu S, Aydin AF,
Beyhan-Özdaş Ş, Yapişlar H, Koçak-Toker N.(PubMed)
(2142) Short-term effect of G-400, polyherbal formulation in the
management of hyperglycemia and hyperlipidemia conditions in patients with type
2 diabetes mellitus by Kurian GA1, Manjusha V2, Nair SS2, Varghese T2,
Padikkala J3.(PubMed)
(2143) Anti-hyperglycemic and insulin sensitizer effects of
turmeric and its principle constituent curcumin by Ghorbani Z1, Hekmatdoost A2,
Mirmiran P3.(PubMed)
(2144) Improvements of insulin resistance in ovariectomized rats
by a novel phytoestrogen from Curcuma comosa Roxb by Prasannarong M1,
Saengsirisuwan V, Piyachaturawat P, Suksamrarn A.(PubMed)
(2145) Antioxidant and vascular protective effects of curcumin and
tetrahydrocurcumin in rats with L-NAME-induced hypertension. Nakmareong S1,
Kukongviriyapan U, Pakdeechote P, Donpunha W, Kukongviriyapan V, Kongyingyoes
B, Sompamit K, Phisalaphong C.(PubMed)
(2146) Curcumin protects against cadmium-induced vascular
dysfunction, hypertension and tissue cadmium accumulation in mice. Kukongviriyapan
U1, Pannangpetch P2, Kukongviriyapan V3, Donpunha W4, Sompamit K5,
Surawattanawan P6.(PubMed)
(2147) Anti-obesity effect of a standardised ethanol extract from
Curcuma longa L. fermented with Aspergillus oryzae in ob/ob mice and primary
mouse adipocytes by Ho JN1, Jang JY, Yoon HG, Kim Y, Kim S, Jun W, Lee J.(PubMed)
(2148) Serum metabonomic analysis of protective effects of Curcuma
aromatica oil on renal fibrosis rats by Zhao L1, Zhang H1, Yang Y2, Zheng Y1,
Dong M1, Wang Y1, Bai G3, Ye X3, Yan Z3, Gao H4.(PubMed)
(2149) Improvements of insulin resistance in ovariectomized rats
by a novel phytoestrogen from Curcuma comosa Roxb by Prasannarong M1,
Saengsirisuwan V, Piyachaturawat P, Suksamrarn A.(PubMed)
(2150) Turmerin: a water soluble antioxidant peptide from turmeric
[Curcuma longa].by Srinivas L1, Shalini VK, Shylaja M.(PubMed)
(2151) Antiproliferative, protective and antioxidant effects of
artichoke, dandelion, turmeric and rosemary extracts and their formulation by
Menghini L1, Genovese S, Epifano F, Tirillini B, Ferrante C, Leporini L.(PubMed)
(2152) Associations between Dietary Antioxidant Intake and
Metabolic Syndrome by Wei J1, Zeng C2, Gong QY1, Li XX1, Lei GH2, Yang TB1.(PubMed)
(2153) Inflammatory markers and cardiometabolic diseases by Esser
N, Paquot N, Scheen AJ.(PubMed)
(2154) Human resistin and the RELM of Inflammation in diabesity by
Al Hannan F1, Culligan KG2.(PubMed)
(2155) Protective effects of ginger-turmeric rhizomes mixture on
joint inflammation, atherogenesis, kidney dysfunction and other
complications in a rat model of human rheumatoid arthritis by Ramadan G1,
El-Menshawy O.(PubMed)
(2157) Comparison of purple carrot juice and β-carotene in a
high-carbohydrate, high-fat diet-fed rat model of the metabolic syndrome by
Poudyal H1, Panchal S, Brown L.(PubMed)
(2158) Purified anthocyanin supplementation reduces dyslipidemia,
enhances antioxidant capacity, and prevents insulin resistance in diabetic
patients by Li D1, Zhang Y2, Liu Y1, Sun R1, Xia M3.(PubMed)
(2159) Anthocyanin supplementation improves serum LDL- and
HDL-cholesterol concentrations associated with the inhibition of cholesteryl
ester transfer protein in dyslipidemic subjects by Qin Y1, Xia M, Ma J, Hao Y,
Liu J, Mou H, Cao L, Ling W.(PubMed)
(2160) An anthocyanin-rich extract from Kamchatka honeysuckle increases
enzymatic activity within the gut and ameliorates abnormal lipid and glucose
metabolism in rats by Jurgoński A1, Juśkiewicz J, Zduńczyk Z(PubMed)
(2161) Phenolic acid composition, antiatherogenic and anticancer
potential of honeys derived from various regions in Greece by Spilioti E1,
Jaakkola M2, Tolonen T2, Lipponen M2, Virtanen V2, Chinou I3, Kassi E1,
Karabournioti S1, Moutsatsou P1.(PubMed)
(2162) Representative Literature on the Phytonutrients Category:
Phenolic Acids by Roche A1, Ross E, Walsh N, O'Donnell K, Williams A, Klapp M,
Fullard N, Edelstein S.(PubMed)
(2163)Carotenoids and health in older people by Woodside JV1,
McGrath AJ2, Lyner N2, McKinley MC2.(PubMed)
(2164) Carotenoids: potential allies of cardiovascular health? by
Gammone MA1, Riccioni G2,3, D'Orazio N2.(PubMed)
(2165) Carotenoids and cardiovascular disease by Riccioni G1.(PubMed)
(2166) Crocetin, a carotenoid derived from saffron (Crocus sativus
L.), improves acetylcholine-induced vascular relaxation in hypertension by
Mancini A1, Serrano-Díaz J, Nava E, D'Alessandro AM, Alonso GL, Carmona M,
Llorens S.(PubMed)
(2167) Benign intracranial hypertension following vitamin A
megadose by Perera PJ1, Sandamal YS, Randeny S.(PubMed)
(2168) Retinoic acid-related orphan receptor γ (RORγ): a novel
participant in the diurnal regulation of hepatic gluconeogenesis and insulin
sensitivity by Takeda Y1, Kang HS1, Freudenberg J2, DeGraff LM1, Jothi R2,
Jetten AM1.(PubMed)
(2169) Plasma concentrations of retinol in obese children and
adolescents: relationship to metabolic syndrome components by Teske M1, Melges
AP2, de Souza FI1, Fonseca FL1, Sarni RO1.(PubMed)
(2170) Effects of Dietary Lycopene Supplementation on Plasma Lipid
Profile, Lipid Peroxidation and Antioxidant Defense System in Feedlot Bamei
Lamb by Jiang H, Wang Z, Ma Y, Qu Y, Lu X, Luo H.(PubMed)
(2171) Human plasma levels of vitamin E and carotenoids are
associated with genetic polymorphisms in genes involved in lipid metabolism by
Borel P1, Moussa M, Reboul E, Lyan B, Defoort C, Vincent-Baudry S, Maillot M,
Gastaldi M, Darmon M, Portugal H, Planells R, Lairon D.(PubMed)
(2172) Tissue- and sex-specific effects of β-carotene 15,15'
oxygenase (BCO1) on retinoid and lipid metabolism in adult and developing mice
by Kim YK1, Zuccaro MV1, Costabile BK1, Rodas R1, Quadro L2.(PubMed)
(2173) Piperine inhibits the activities of platelet cytosolic
phospholipase A2 and thromboxane A2 synthase without affecting cyclooxygenase-1
activity: different mechanisms of action are involved in the inhibition of
platelet aggregation and macrophage inflammatory response by Son DJ1, Akiba S2,
Hong JT3, Yun YP4, Hwang SY5, Park YH6, Lee SE7.(PubMed)
(2174) Piperine, a Bioactive Component of Pepper Spice Exerts
Therapeutic Effects on Androgen Dependent and Androgen Independent Prostate
Cancer Cells by Samykutty A1, Shetty AV, Dakshinamoorthy G, Bartik MM, Johnson
GL, Webb B, Zheng G, Chen A, Kalyanasundaram R, Munirathinam G.(PubMed)
(2175) Antioxidant potential of spices and their active
constituents by Srinivasan K1.(PubMed)
(2176) Inhibitory effects of black pepper (Piper nigrum) extracts
and compounds on human tumor cell proliferation, cyclooxygenase enzymes, lipid
peroxidation and nuclear transcription factor-kappa-B by Liu Y1, Yadev VR,
Aggarwal BB, Nair MG.(PubMed)
(2177) Antispasmodic effect of Piper nigrum fruit hot water
extract on rat ileum by Naseri MK1, Yahyavi H.(PubMed)
(2178) Pharmacological basis for the medicinal use of black pepper
and piperine in gastrointestinal disorders by Mehmood MH1, Gilani AH.(PubMed)
(2179) Blood pressure lowering and vasomodulator effects of
piperine by Taqvi SI1, Shah AJ, Gilani AH.(PubMed)
(2180) Black pepper(MDidea)
(2181) Antioxidant and anti-inflammatory effects of
curcuminoid-piperine combination in subjects with metabolic syndrome: A
randomized controlled trial and an updated meta-analysis by Panahi Y1, Hosseini
MS2, Khalili N2, Naimi E2, Majeed M3, Sahebkar A4.(PubMed)
(2182) Lipid-modifying effects of adjunctive therapy with
curcuminoids-piperine combination in patients with metabolic syndrome: results
of a randomized controlled trial by Panahi Y1, Khalili N2, Hosseini MS2,
Abbasinazari M3, Sahebkar A4.(PubMed)
(2183) Amelioration of obesity, glucose intolerance, and oxidative
stress in high-fat diet and low-dose streptozotocin-induced diabetic rats by
combination consisting of "curcumin with piperine and quercetin"
byKaur G1, C M.(PubMed)
(2184) Piperine, a natural bioenhancer, nullifies the antidiabetic
and antioxidant activities of curcumin in streptozotocin-diabetic rats by
Arcaro CA1, Gutierres VO1, Assis RP1, Moreira TF1, Costa PI1, Baviera AM1,
Brunetti IL1.(PubMed)
(2185) Elucidation of the Inhibitory Effect of Phytochemicals with
Kir6.2 Wild-Type and Mutant Models Associated in Type-1 Diabetes through
Molecular Docking Approach by Jagadeb M1, Konkimalla VB2, Rath SN1, Das RP1.(PubMed)
(2186) Piperine attenuates cardiovascular, liver and metabolic
changes in high carbohydrate, high fat-fed rats by Diwan V1, Poudyal H, Brown
L.(PubMed)
(2187) Mitigating efficacy of piperine in the physiological
derangements of high fat diet induced obesity in Sprague Dawley rats by
BrahmaNaidu P1, Nemani H2, Meriga B3, Mehar SK4, Potana S2, Ramgopalrao S5.(PubMed)
(2188) Efficacy of piperine, an alkaloidal constituent from Piper
nigrum on erythrocyte antioxidant status in high fat diet and antithyroid drug
induced hyperlipidemic rats by Vijayakumar RS1, Nalini N.(PubMed)
(2189) Screening of antidiabetic and antihyperlipidemic potential
of oil from Piper longum and piperine with their possible mechanism by Kumar
S1, Sharma S, Vasudeva N.(PubMed)((2190)
Fan shi liu(Complementary
and Alternative Healing University)
(2191) Growth inhibitory effects of crude pomegranate peel extract
on chronic myeloid leukemia, K562 cells by Asmaa MJ1, Ali AJ1, Farid JM1, Azman
S2.(PubMed)
(2192) The anti-biofilm potential of pomegranate (Punica granatum
L.) extract against human bacterial and fungal pathogens by Bakkiyaraj D1,
Nandhini JR, Malathy B, Pandian SK.(PubMed)
(2193) The antioxidant potency of Punica granatum L. Fruit peel
reduces cell proliferation and induces apoptosis on breast cancer by Dikmen M1,
Ozturk N, Ozturk Y.(PubMed)
(2194) Punica granatum (pomegranate) and its potential for
prevention and treatment of inflammation and cancer by Lansky EP1, Newman RA.(PubMed)
(2195) Antimicrobial and free radical scavenging activities of
five Palestinian medicinal plants by Qabaha KI1.(PubMed)
(2196) Pomegranate from Oman Alleviates the Brain Oxidative Damage
in Transgenic Mouse Model of Alzheimer's disease by Subash S1, Essa MM2,
Al-Asmi A3, Al-Adawi S3, Vaishnav R4, Braidy N5, Manivasagam T6, Guillemin
GJ7.(PubMed)
(2197) Pomegranate extract modulates processing of amyloid-β
precursor protein in an aged Alzheimer's disease animal model by Ahmed AH,
Subaiea GM, Eid A, Li L, Seeram NP, Zawia NH1.(PubMed)
(2198) Antinociceptive and anti-inflammatory activities of a
pomegranate (Punica granatum L.) extract rich in ellagitannins by
González-Trujano ME1, Pellicer F, Mena P, Moreno DA, García-Viguera C.(PubMed)
(2199) Topical anti-inflammatory and analgesic activities of
standardized pomegranate rind extract in comparison with its marker compound
ellagic acid in vivo by Mo J1, Panichayupakaranant P, Kaewnopparat N,
Nitiruangjaras A, Reanmongkol W.(PubMed)
(2200) Anti-coccidial, anthelmintic and antioxidant activities of
pomegranate (Punica granatum) peel extract by Dkhil MA1.(PubMed)
(2201) Pomegranate: a fruit that ameliorates metabolic syndrome by
Medjakovic S1, Jungbauer A.(PubMed)
(2202) Acute and long term effects of grape and pomegranate juice
consumption on endothelial dysfunction in pediatric metabolic syndrome by Kelishadi
R1, Gidding SS, Hashemi M, Hashemipour M, Zakerameli A, Poursafa P.(PubMed)
(2203) Pomegranate seed oil consumption during a period of
high-fat feeding reduces weight gain and reduces type 2 diabetes risk in CD-1
mice by McFarlin BK1, Strohacker KA, Kueht ML.(PubMed)
(2204) Effect of pomegranate juice on paraoxonase enzyme activity
in patients with type 2 diabetes by Parsaeyan N1, Mozaffari-Khosravi H, Mozayan
MR.(PubMed)
(2205) Extracts of black bean peel and pomegranate peel ameliorate
oxidative stress-induced hyperglycemia in mice by Wang JY1, Zhu C1, Qian TW1,
Guo H1, Wang DD1, Zhang F1, Yin X1.(PubMed)
(2206) Fresh pomegranate juice ameliorates insulin resistance,
enhances β-cell function, and decreases fasting serum glucose in type 2
diabetic patients by Banihani SA1, Makahleh SM2, El-Akawi Z3, Al-Fashtaki RA2,
Khabour OF4, Gharibeh MY2, Saadah NA5, Al-Hashimi FH2, Al-Khasieb NJ3.(PubMed)
(2207) Preventive and prophylactic mechanisms of action of
pomegranate bioactive constituents by Viladomiu M1, Hontecillas R, Lu P,
Bassaganya-Riera J.(PubMed)
(2208) Obesity: the preventive role of the pomegranate (Punica
granatum) by Al-Muammar MN1, Khan F.(PubMed)
(2209) Pomegranate extract (POMx) decreases the atherogenicity of
serum and of human monocyte-derived macrophages (HMDM) in simvastatin-treated
hypercholesterolemic patients: a double-blinded, placebo-controlled,
randomized, prospective pilot study by Hamoud S1, Hayek T2, Volkova N3, Attias
J4, Moscoviz D1, Rosenblat M3, Aviram M5.(PubMed)
(2210) Acute effects of pomegranate extract on postprandial
lipaemia, vascular function and blood pressure by Mathew AS1, Capel-Williams
GM, Berry SE, Hall WL.(PubMed)
(2211) Clinical evaluation of blood pressure lowering, endothelial
function improving, hypolipidemic and anti-inflammatory effects of pomegranate
juice in hypertensive subjects by Asgary S1,
Sahebkar A, Afshani MR, Keshvari M, Haghjooyjavanmard S,
Rafieian-Kopaei M.(PubMed)
(2222) A licorice ethanolic extract with peroxisome
proliferator-activated receptor-gamma ligand-binding activity affects diabetes
in KK-Ay mice, abdominal obesity in diet-induced obese C57BL mice and
hypertension in spontaneously hypertensive rats by Mae T1, Kishida H, Nishiyama
T, Tsukagawa M, Konishi E, Kuroda M, Mimaki Y, Sashida Y, Takahashi K, Kawada
T, Nakagawa K, Kitahara M.(PubMed)
(2223) 18β-glycyrrhetinic acid attenuates anandamide-induced
adiposity and high-fat diet induced obesity by Park M1, Lee JH, Choi JK, Hong
YD, Bae IH, Lim KM, Park YH, Ha H.(PubMed)
(2224) Effect of licorice extract on the complications of diabetes
nephropathy in rats by Kataya HH1, Hamza AA, Ramadan GA
(2225) Glycyrrhetinic Acid protects the heart from ischemia/reperfusion
injury by attenuating the susceptibility and incidence of fatal ventricular
arrhythmia during the reperfusion period in the rat hearts by Wu HJ1, Yang JY,
Jin M, Wang SQ, Wu DL, Liu YN, Yan X, Yang C, Zhang G, He J.(PubMed)
(2226) Glycyrrhiza glabra protects from myocardial
ischemia-reperfusion injury by improving hemodynamic, biochemical,
histopathological and ventricular function by Ojha S1, Golechha M, Kumari S,
Bhatia J, Arya DS.(PubMed)
(2227) A Review: The Pharmacology of Isoliquiritigenin by Peng F1,
Du Q, Peng C, Wang N, Tang H, Xie X, Shen J, Chen J.(PubMed)
(2228) Dong chong xia cao(Complementary and
Alternative Healing University)
(2229) [Effect of cordyceps sinensis on cellular immunity in rats
with chronic renal insufficiency]. [Article in Chinese] by Cheng Q1.(PubMed)
(2230) Comparisons on enhancing the immunity of fresh and dry
Cordyceps militaris in vivo and in vitro by Zhu SJ1, Pan J, Zhao B, Liang J,
Ze-Yu W, Yang JJ.(PubMed)
(2231) Phytochemical and antimicrobial activities of Himalayan
Cordyceps sinensis (Berk.) by Sacc. Mamta, Mehrotra S, Amitabh, Kirar V, Vats
P, Nandi SP, Negi PS, Misra K.(PubMed)
(2232) Hot-water extract from mycelia of Cordyceps sinensis as a
substitute for antibiotic growth promoters by Koh JH1, Suh HJ, Ahn TS.(PubMed)
(2233) Antioxidant activity of the extracts from fruiting bodies
of cultured Cordyceps sinensis by Yamaguchi Y1, Kagota S, Nakamura K, Shinozuka
K, Kunitomo M.(PubMed)
(2234) Anti-oxidation activity of different types of natural
Cordyceps sinensis and cultured Cordyceps mycelia by Li SP1, Li P, Dong TT,
Tsim KW.(PubMed)
(2235) Anti-inflammatory principles from Cordyceps sinensis by
Yang ML1, Kuo PC, Hwang TL, Wu TS.(PubMed)
(2236) Evaluation of the anti-inflammatory and anti-proliferation
tumoral cells activities of Antrodia camphorata, Cordyceps sinensis, and
Cinnamomum osmophloeum bark extracts by Rao YK1, Fang SH, Tzeng YM.(PubMed)
(2237) Anti-tumor effect of Cordyceps militaris in HCV-infected
human hepatocarcinoma 7.5 cells by Lee S1, Lee HH, Kim J, Jung J, Moon A, Jeong
CS, Kang H, Cho H.(PubMed)
(2238) Toxicity evaluation of cordycepin and its delivery system
for sustained in vitro anti-lung cancer activity by Aramwit P1, Porasuphatana
S2, Srichana T3, Nakpheng T3.(PubMed)
(2239) [Current studies and prospect of anti-thrombotic effect of
Cordyceps fungi]. [Article in Chinese] by Li XG1, Xiao JH1.(PubMed)
(2240) Protective effect of extract of Cordyceps sinensis in
middle cerebral artery occlusion-induced focal cerebral ischemia in rats by Liu
Z1, Li P, Zhao D, Tang H, Guo J.(PubMed)
(2241) Role of dongchongxiacao (Cordyceps) in prevention of
contrast-induced nephropathy in patients with stable angina pectoris by Zhao
K1, Li Y, Zhang H.(PubMed)
(2242) [Cordyceps mycelia extract decreases portal hypertension in
rats with dimethylnitrosamine-induced liver cirrhosis: a study on its
histological basis]. [Article in Chinese] by Wang XB1, Liu P, Tang ZP, Li FH,
Liu CH, Hu YY, Xu LM.(PubMed)
(2243) [Acting mechanism of Cordyceps mycelia extract for
antagonizing hepatic sinusoidal capillarization in rats with
dimethylnitrosamine induced liver cirrhosis]. [Article in Chinese] by Wang XB1,
Liu P, Tang ZP.(PubMed)
(2244) Anti-inflammatory and antinociceptive effects of cordymin,
a peptide purified from the medicinal mushroom Cordyceps sinensis by Qian GM1,
Pan GF, Guo JY.(PubMed)
(2245) Cordycepin alleviates airway hyperreactivity in a murine
model of asthma by attenuating the inflammatory process by Yang X1, Li Y1, He
Y1, Li T1, Wang W2, Zhang J3, Wei J4, Deng Y5, Lin R6.(PubMed)
(2246) The extract of Cordyceps sinensis inhibited airway
inflammation by blocking NF-κB activity by Chiou YL1, Lin CY.(PubMed)
(2247) [Investigation of compound, compatibility of Rhodiola
crenulata, Cordyceps militaris, and Rhum palmatum, on metabolic syndrome
treatment VI--improving hyperglycemia-mediated renal damage]. [Article in
Chinese] Fu JY1, Zhang XL2, Tian JY2, Huang LW2, Zhang PC3, Ye F2.(PubMed)
(2248) [Investigation of a compound, compatibility of Rhodiola
crenulata, Cordyceps militaris, and Rhum palmatum, on metabolic syndrome
treatment. IV--Improving liver lipid accumulation]. [Article in Chinese] by Li
J1, Zhang XL, Liu YY, Chen L, Tian JY, Han JY, Zhang PC, Ye F.(PubMed)
(2249) [Investigation of a compound, compatibility of Rhodiola
crenulata, Cordyceps militaris, and Rheum palmatum, on metabolic syndrome
treatment I--improving insulin resistance]. [Article in Chinese] by Li J1, Chen
L, Zhang X, Fu J, Han J, Tian J, Zhang P, Ye F.(PubMed)
(2250) [Investigation of a compound, compatibility of Rhodiola
crenulata, Cordyceps militaris, and Rheum palmatum, on metabolic syndrome
treatment. V--Mechanisms on improving glucose metabolic disorders]. [Article in
Chinese] Wang L1, Zhang XL, Li MH, Tian JY, Zhang PC, Ye F.(PubMed)
(2251) Cordycepin from Cordyceps militaris prevents hyperglycemia
in alloxan-induced diabetic mice by Ma L1, Zhang S2, Du M3.(PubMed)
(2252) Anti-hyperglycemic activity of natural and fermented
Cordyceps sinensis in rats with diabetes induced by nicotinamide and
streptozotocin. Lo HC1, Hsu TH, Tu ST
(2253) Lipid-lowering effect of cordycepin (3'-deoxyadenosine)
from Cordyceps militaris on hyperlipidemic hamsters and rats by Gao J1, Lian
ZQ, Zhu P, Zhu HB.(PubMed)
(2254) Cordycepin prevents hyperlipidemia in hamsters fed a
high-fat diet via activation of AMP-activated protein kinase by Guo P1, Kai Q,
Gao J, Lian ZQ, Wu CM, Wu CA, Zhu HB.(PubMed)
(2255) [Investigation of a compound, compatibility of Rhodiola
crenulata, Cordyceps militaris, and Rheum palmatum, on metabolic syndrome
treatment II - improving obesity]. [Article in Chinese] by Tian JY1, Chen L,
Zhang XL, Li J, Han J, Fu JY, Yang XM, Zhang PC, Ye F.(PubMed)
(2256) Blockade of adipocyte differentiation by cordycepin.
Takahashi S1, Tamai M, Nakajima S, Kato H, Johno H, Nakamura T, Kitamura M.(PubMed)
(2257) Effect of Cordyceps militaris supplementation on sperm
production, sperm motility and hormones in Sprague-Dawley rats by Chang Y1,
Jeng KC, Huang KF, Lee YC, Hou CW, Chen KH, Cheng FY, Liao JW, Chen YS.(PubMed)
(2258) Upregulation of steroidogenic enzymes and ovarian
17beta-estradiol in human granulosa-lutein cells by Cordyceps sinensis mycelium
by Huang BM1, Hsiao
KY
(2259) Role of Cordycepin and Adenosine on the Phenotypic Switch
of Macrophages via Induced Anti-inflammatory Cytokines by Shin S1, Moon S, Park
Y, Kwon J, Lee S, Lee CK, Cho K, Ha NJ, Kim K.(PubMed)
(2260) Cordycepin Suppresses Expression of Diabetes Regulating
Genes by Inhibition of Lipopolysaccharide-induced Inflammation in Macrophages
by Shin S1, Lee S, Kwon J, Moon S, Lee S, Lee CK, Cho K, Ha NJ, Kim K.(PubMed)
(2261) Cardiovascular protection and antioxidant activity of the
extracts from the mycelia of Cordyceps sinensis act partially via adenosine
receptors by Yan XF1, Zhang ZM, Yao HY, Guan Y, Zhu JP, Zhang LH, Jia YL, Wang
RW.(PubMed)
(2262) Protective effect of extract of Cordyceps sinensis in
middle cerebral artery occlusion-induced focal cerebral ischemia in rats by Liu
Z1, Li P, Zhao D, Tang H, Guo J.(PubMed)
(2263) , inhibit Inhibitory Mechanisms of CME-1, a Novel
Polysaccharide from the Mycelia of Cordyceps sinensis, in Platelet Activation
by Chang YI, Hsu WH, Lu WJ, Jayakumar T, Liao JC, Lin MJ, Wang SH, Geraldine P,
Lin KH, Sheu JR1.(PubMed)
(2264) Anti-hypertensive effects of shichimotsukokato in 5/6
nephrectomized Wistar rats mediated by the DDAH-ADMA-NO pathway by Bai F1,
Makino T, Ono T, Mizukami H.(PubMed)
(2265) [Effects of Salviae miltiorrhizae and salvianolic acid
B on microcirculation of liver in mice with portal hypertension]. [Article in
Chinese] by Tian T1, Xu LM.(PubMed)
(2266) Astragaloside IV attenuates proteinuria in
streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic
reticulum stress by Wang ZS1, Xiong F2, Xie XH3, Chen D4, Pan JH5, Cheng L6.(PubMed)
(2267) [Changes in proteinuria, renal function and immunity
after treatment with injections of a solution of Astragalus membranaceus].
[Article in Chinese] by Dong DC
(2268) Astragalus membranaceus improves exercise performance
and ameliorates exercise-induced fatigue in trained mice by Yeh TS1, Chuang
HL2, Huang WC3, Chen YM4, Huang CC5, Hsu MC6.(PubMed)
(2269) Astragalus membranaceus flavonoids (AMF) ameliorate
chronic fatigue syndrome induced by food intake restriction plus forced
swimming by Kuo YH1, Tsai WJ, Loke SH, Wu TS, Chiou WF.(PubMed)
(2270) Protective effect of extract from Paeonia lactiflora
and Astragalus membranaceus against liver injury induced by bacillus
Calmette-Guérin and lipopolysaccharide in mice by Sun WY1, Wei W, Gui SY, Wu L,
Wang H.(PubMed)
(2271) Effects and mechanisms of extract from Paeonia
lactiflora and Astragalus membranaceus on liver fibrosis induced by carbon
tetrachloride in rats by Sun WY1, Wei W, Wu L, Gui SY, Wang H.(PubMed)
(2272) Compound Astragalus and Salvia miltiorrhiza extracts
modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by
multi-target mechanism by Boye A1, Wu C1, Jiang Y1, Wang J1, Wu J1, Yang X1,
Yang Y2.(PubMed)
(2273) Astragalus (a traditional Chinese medicine) for
treating chronic kidney disease by Zhang HW1, Lin ZX, Xu C, Leung C, Chan LS.(PubMed)
(2274) Effects of an astragalus polysaccharide and rhein
combination on apoptosis in rats with chronic renal failure. by Lian Y1, Xie
L1, Chen M2, Chen L3.(PubMed)
(2275) [Therapeutic effect of Astragalus and Angelica mixture
on the renal function and TCM syndrome factors in treating stage 3 and 4
chronic kidney disease patients]. [Article in Chinese] by Li S, Yin XX, Su T,
Cao C, Li X, Rao XR, Li X.(PubMed)
(2276) Cycloastragenol, a triterpene aglycone derived from
Radix astragali, suppresses the accumulation of cytoplasmic lipid droplet in
3T3-L1 adipocytes by Wang S1, Zhai C1, Liu Q1, Wang X1, Ren Z1, Zhang Y1, Zhang
Y1, Wu Q2, Sun S2, Li S3, Qiao Y4.(PubMed)
(2277) [Radix Astragali improves impaired endothelial
dependent vasodilation in obese rat]. [Article in Chinese] by Deng G1, Yu YR.(PubMed)
(2278) Astragalus polysaccharides: an effective treatment for
diabetes prevention in NOD mice by Chen W1, Li Y-, Yu M-.(PubMed)
(2279) Astragalus polysaccharide suppresses skeletal muscle
myostatin expression in diabetes: involvement of ROS-ERK and NF-κB pathways by
Liu M1, Qin J2, Hao Y3, Liu M4, Luo J5, Luo T4, Wei L6.(PubMed)
(2280) [Clinical evaluation of the antioxidant activity of
astragalus in women with gestational diabetes]. [Article in Chinese] by Liang
HY1, Hou F, Ding YL, Zhang WN, Huang XH, Zhang BY, Liu Y.(PubMed)
(2281) Astragalus polysaccharide attenuates
isoproterenol-induced cardiac hypertrophy by regulating TNF-α/PGC-1α signaling
mediated energy biosynthesis by Luan A1, Tang F2, Yang Y2, Lu M2, Wang H3,
Zhang Y4.(PubMed)
(2282) Astragaloside IV protects against
isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling
mediated energy biosynthesis by Zhang S1, Tang F1, Yang Y1, Lu M1, Luan A1,
Zhang J1, Yang J1, Wang H1.(PubMed)
(2283) [Effects of astragalus and its active ingredients on
ischemia reperfusion injury in isolated guinea-pig heart]. [Article in Chinese]
by Zhang H1, Min D, Fu M, Tian J, Wang Q, An X2.(PubMed)
(2284) Alfalfa seeds lower low density lipoprotein
cholesterol and apolipoprotein B concentrations in patients with type II
hyperlipoproteinemia by Mölgaard J, von Schenck H, Olsson AG.(PubMed)
(2285) Digital gene-expression profiling analysis of the
cholesterol-lowering effects of alfalfa saponin extract on laying hens by Zhou
L1, Shi Y1, Guo R1, Liang M1, Zhu X1, Wang C1.(PubMed)
(2286) Experimental models of atherosclerosis regression by
Malinow MR.(PubMed)
(2287) Effect of alfalfa meal on shrinkage (regression) of
atherosclerotic plaques during cholesterol feeding in monkeys by Malinow MR,
McLaughlin P, Naito HK, Lewis LA, McNulty WP.(PubMed)
(2288) Cytotoxicity and apoptosis induced by alfalfa
(Medicago sativa) leaf extracts in sensitive and multidrug-resistant tumor
cells by Gatouillat G1, Magid AA, Bertin E, Okiemy-Akeli MG, Morjani H, Lavaud
C, Madoulet C.(PubMed)
(2289) Double-edged sword effect of biochanin to inhibit
nuclear factor kappaB: suppression of serine/threonine and tyrosine kinases by
Manna SK1.(PubMed)
(2290) Pancreatic and extra-pancreatic effects of the
traditional anti-diabetic plant, Medicago sativa (lucerne) by Gray AM1, Flatt
PR.(PubMed)
(2291) Traditional plant treatments for diabetes. Studies in
normal and streptozotocin diabetic mice by Swanston-Flatt SK1, Day C, Bailey
CJ, Flatt PR.(PubMed)
(2292) Health effects of phytoestrogens by Branca F1,
Lorenzetti S.(PubMed)
(2293) [Treatment of neurovegetative menopausal symptoms with
a phytotherapeutic agent]. [Article in Italian] by De Leo V1, Lanzetta D,
Cazzavacca R, Morgante G.(PubMed)
(2294) Evaluation of Antioxidant and Cerebroprotective Effect
of Medicago sativa Linn. against Ischemia and Reperfusion Insult by Bora KS1,
Sharma A.(PubMed)
(2295) Phytochemical and pharmacological potential of
Medicago sativa: a review by Bora KS1, Sharma A.(PubMed)
(2296) The effect of dietary alfalfa and flax sprouts on
rabbit meat antioxidant content, lipid oxidation and fatty acid composition by
Dal Bosco A1, Castellini C2, Martino M2, Mattioli S2, Marconi O2, Sileoni V2,
Ruggeri S2, Tei F2, Benincasa P2.(PubMed)
(2297) Pseudomonas fluorescens Pf-5 genome-wide mutant screen
for resistance to the antimicrobial peptide alfalfa snakin-1. Ayub ND1, Fox
AR1, García AN2, Mozzicafreddo M3, Cuccioloni M3, Angeletti M3, Pagano E2, Soto
G4.(PubMed)
(2298) Estrogenic activity of fermented alfalfa by Jorgensen
NA, Freymiller DD.(PubMed)
(2299) [Anti-estrogenic action of some alfalfa varieties].
[Article in Bulgarian] by Bonkov N, Petrova S, Khadzhiiski D.(PubMed)
(2300) The effect of mixing and changing the order of feeding
oats and chopped alfalfa to horses on: glycaemic and insulinaemic responses,
and breath hydrogen and methane production by Vervuert I1, Voigt K, Hollands T,
Cuddeford D, Coenen M.(PubMed)
(2301) Ghrelin differentially modulates glucose-induced
insulin secretion according to feeding status in sheep by Takahashi H1, Kurose
Y, Sakaida M, Suzuki Y, Kobayashi S, Sugino T, Kojima M, Kangawa K, Hasegawa Y,
Terashima Y.(PubMed)
(2302) Nutritional quality of legumes, and their role in
cardiometabolic risk prevention: a review by Bouchenak M1, Lamri-Senhadji M.(PubMed)
(2303) Digital gene-expression profiling analysis of the
cholesterol-lowering effects of alfalfa saponin extract on laying hens. Zhou
L1, Shi Y1, Guo R1, Liang M1, Zhu X1, Wang C1.(PubMed)
(2304) Effects of alfalfa on lipoproteins and fatty streak
formation in hypercholesterolemic rabbits. Asgary S1, Moshtaghian J, Hosseini
M, Siadat H.(PubMed)
(2305) Effects of dietary fiber of young adult genetically
lean, obese and contemporary pigs: rate of passage, digestibility and
microbiological data by Varel VH1, Jung HG, Pond WG.(PubMed)
(2306) Effect of dietary fiber on young adult genetically
lean, obese and contemporary pigs: body weight, carcass measurements, organ
weights and digesta content by Pond WG1, Jung HG, Varel VH.(PubMed)
(2307)Du zhong((Complementary and
Alternative Healing University)
(2308) The effects of certain immunity systemic advuvants,
PHA, and human gamma globulin on the thymic cortex of mice: a light and
electron microscope study by Khalil A, Rappaport H, Dantchev D, Florentin I,
Bourut C.(PubMed)
(2309)[Chemical constituents of Eucommia ulmoides]. [Article in
Chinese] by Wang SY, Ding LF, Wu XD, Wang HY, Zhao QS, Song LD.(PubMed)
(2310) [Comparison of immunity improving effects of different
processed cortex Eucommiae] [Article in Chinese] by Zhu Y1, Hao W, Li X.(PubMed)
(2311) Chinese Acupuncture and Herbal Medicine Clinical
Reference By Paul
Robin, Paul Brecher
(2312) [Adjunctive treatment of axial undifferentiated
spondyloarthritis by Qiangji Recipe: a clinical study]. [Article in Chinese] by
He MY, Fan FY.(PubMed)
(2313) [Effect of bushen qiangdu recipe on osteoporosis and
bone loss of patients with ankylosing spondylitis]. [Article in Chinese] by
Wang H1, Yan XP, Kong WP.(PubMed)
(2314) Elucidation of anti-inflammatory potencies of Eucommia
ulmoides bark and Plantago asiatica seeds by Kim BH1, Park KS
(2315) [Investigation of a compound, compatibility of
Rhodiola crenulata, Cordyceps militaris, and Rheum palmatum on metabolic
syndrome treatment III--controlling blood glucose]. [Article in Chinese]
by Tian JY1, Chen L, Zhang XL, Li J, Han J, Yang XM, Zhang PC, Du PG, An
LP, Ye F.(PubMed)
(2316) Eucommia ulmoides Oliv.: ethnopharmacology, phytochemistry
and pharmacology of an important traditional Chinese medicine. He X1, Wang J2,
Li M3, Hao D1, Yang Y4, Zhang C1, He R1, Tao R5.(PubMed)
(2317) Anti-obesity compounds in green leaves of Eucommia
ulmoides by Hirata T1, Kobayashi T, Wada A, Ueda T, Fujikawa T, Miyashita H,
Ikeda T, Tsukamoto S, Nohara T.(PubMed)
(2318) Chronic administration of Eucommia leaf stimulates
metabolic function of rats across several organs by Fujikawa T1, Hirata T, Wada
A, Kawamura N, Yamaguchi Y, Fujimura K, Ueda T, Yurugi Y, Soya H, Nishibe S.(PubMed)
(2319) A clinical trial testing the safety and efficacy of a
standardized Eucommia ulmoides Oliver bark extract to treat hypertension by
Greenway F1, Liu Z, Yu Y, Gupta A.(PubMed)
(2320) Effects of lignans extracted from Eucommia ulmoides
and aldose reductase inhibitor epalrestat on hypertensive vascular remodeling
by Gu J1, Wang JJ, Yan J, Cui CF, Wu WH, Li L, Wang ZS, Yu M, Gao N, Liu L,
Ouyang DS.(PubMed)
(2321) Antihypertensive effect of Eucommia ulmoides Oliv.
extracts in spontaneously hypertensive rats by Luo LF1, Wu WH, Zhou YJ, Yan J,
Yang GP, Ouyang DS.(PubMed)
(2322) Role of angiotensin II in blood pressure regulation
and in the pathophysiology of cardiovascular disorders by Fyhrquist F1,
Metsärinne K, Tikkanen I.
(2323) Lignans from the bark of Eucommia ulmoides inhibited
Ang II-stimulated extracellular matrix biosynthesis in mesangial cells by Li
ZY, Deng XL, Huang WH, Li L, Li H, Jing X, Tian YY, Lv PY, Yang TL, Zhou HH,
Ouyang DS1.(PubMed)
(2324) Eucommia ulmoides Oliver leaf extract increases
endogenous antioxidant activity in type 2 diabetic mice by Park SA1, Choi MS,
Jung UJ, Kim MJ, Kim DJ, Park HM, Park YB, Lee MK.(PubMed)
(2325) Hypoglycemic and hypolipidemic action of Du-zhong
(Eucommia ulmoides Oliver) leaves water extract in C57BL/KsJ-db/db mice by Park
SA1, Choi MS, Kim MJ, Jung UJ, Kim HJ, Park KK, Noh HJ, Park HM, Park YB, Lee
JS, Lee MK.(PubMed)
(2326) Herbal prescription Chang'an II repairs intestinal
mucosal barrier in rats with post-inflammation irritable bowel syndrome by Wang
FY1, Su M2, Zheng YQ3, Wang XG1, Kang N1, Chen T1, Zhu EL1, Bian ZX4, Tang
XD1.(PubMed)
(2327) he correlation between neurosteroids and
neurotransmitters with liver yang rising and liver qi stagnation types of
premenstrual syndrome by Gao H1, Shang YZ, Xia T, Qiao MQ, Zhang HY, Ma YX.(PubMed)
(2328) [Effects of electroacupuncture on embryo implanted
potential for patients with infertility of different symptom complex]. [Article
in Chinese] by Kong FY1, Zhang QY, Guan Q, Jian FQ, Sun W, Wang Y.(PubMed)
(2329) [Preliminary study on relationship of
disease-syndrome-symptom of ovulatory disorder infertility based on factor
analysis]. [Article in Chinese] by Li M, Ma K, Shan J.(PubMed)
(2330) A preliminary study of the effectiveness of chinese
therapeutic food on regulating female reproductive hormones by Fu L1, Xu H.(PubMed)
(2331) The mind-tranquilizing and menstruation-regulating method
for acupuncture treatment of delayed menstrual cycle--a clinical controlled
study by Cai XM1, Wu J.(PubMed)
(2332) [Preliminary study on
relationship of disease-syndrome-symptom of ovulatory disorder infertility
based on factor analysis].[Article in Chinese] by Li M, Ma K, Shan J.(PubMed)
(2333) [A further research on physiopathological basis of "Liver Yang Forming Wind Syndrome"].[Article in Chinese]Li JB1, Li Y, Xiong GL, Li XW, Zhang XH, Chen CR, Yin Q.(PubMed)
1. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(Part I) - The Prevention
2. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies (Part II)- The Conventional Supplement page
3. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(Part III) - The Weight loss approach
5. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(Part V) - The TCM approach
7. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(References page of 700 -1499)
(2333) [A further research on physiopathological basis of "Liver Yang Forming Wind Syndrome"].[Article in Chinese]Li JB1, Li Y, Xiong GL, Li XW, Zhang XH, Chen CR, Yin Q.(PubMed)
1. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(Part I) - The Prevention
2. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies (Part II)- The Conventional Supplement page
3. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(Part III) - The Weight loss approach
5. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(Part V) - The TCM approach
7. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(References page of 700 -1499)
